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CHAPTER I 
INTRODUCTION 
A. Chemistry of Glomerular Basement Membrane and Group 
A Type 12 Streptococcal Cell Membrane Antigens 
The immunologic relatedness of the group A.type 12 
streptococcal cell membrane (SCM) and human glomerular 
basement membrane (GBM) has been documented by the use of 
immunodiffusion analysis (3, 29), passive hemagglutination 
(25, 29), and indirect fluorescent antibody tests (3, 4, 5). 
The chemical basis for the observed immunochemical cross-
reactivity of the two membrane preparations remains to be 
elucidated. 
1. ~· Present knowledge of the chemical structure of 
human GBM consists mainly of amino acid and carbohydrate 
analyses supplemented by theoretical considerations on a 
possible macromolecular structure for GBM. Table lA con-
tains several determinations by independent investigators 
on the amino acid content of whole human GBM. Table lB 
contains percentages of the main carbohydrate constituents 
of human GBM as determined by the same group of investi-
gators. 
1 
2 
Table 1. Amino acid and carbohydrate composition of human 
glomerular basement membrane. 
A. Amino acid composition (Residues/1,000 
amino acid residues) 
I ( 29) II ( 2) III (34) 
Hydroxylysine 17.0 24 .. 5 28.0 
Lysine 22.0 26.4 23.0 
Histidine 11.0 18.7 20.4 
Arginine 37.0 48.3 49.0 
Hydroxyproline 79.0 65.0 84.2 
Aspartic Acid 70.0 70.0 71.8 
Threonine 37.0 40.3 39.0 
Serine 55.0 54.2 55.0 
Glutamic Acid 95.0 101.3 98.1 
Proline 70.0 64.1 70.9 
Glycine 244.0 225.2 191.0 
Alanine 70.0 58.6 54.3 
Half Cystine 9.0 22.0 20.1 
Valine 36.0 36.0 32.5 
Methionine 15.0 7.0 11.4 
Isoleuc:i,ne 26.0 28.6 34.1 
Leucine 62.0 60.3 68.1 
Tyrosine 17.0 20.5 18.3 
Phenylalanine 29.0 28.3 29.3 
B. Carbohydrate Composition (mg carbohydrate/ 
100 mg protein) 
I ( 29) II ( 2) III (34) 
Hexose 5.6 6.8 7.1 
Hexosamine 0.95 2.0 1.48 
Fucose 0.58 0.7 0.19 
Sialic Acid 0.55 1.5 0.87 
3 
Markowitz and Lange (29) isolated and characterized 
a soluble fraction (PGT-HUGL) of human GBM following tryp-
sinization and extraction with trifluorotrichloroethane 
(Genetron). The PGT-HUGL had am. w. of approximately 
20,000 as determined by its retention on Sephadex G-75, 
sedimentation velocity and amino acid analysis. The PGT-
HUGL contained a 2 to 3 fold increase in carbohydrate content 
over the native human GBM, indicating that trypsin had cleaved 
portions of the protein while areas of the GBM rich in carbo-
hydrate remained intact (29). The carbohydrate fraction of 
PGT-HUGL was composed of galactosamine, glucosamine, galac-
tose, glucose, mannose, and fucose. It was speculated that 
the oligosaccharide chain(s) was linked to the protein via 
asparagine (23). 
Material from the first fraction obtained by chro-
matography of PGT-HUGL on DEAE-cellulose (elution at PH 7.75 
0.01 M phosphate buffer) was digested with papain (25). 
The digest was subjected to high voltage electrophoresis and 
chromatography to obtain a peptide map. The main glyco-
peptides from several runs were pooled respectively and anal-
ysed for amino acid content. The amino acid analyses of 
whole GBM, trypsin resistant GBM, PGT-HUGL, and five frac-
-4 
tions from the peptide maps were compared. Hydroxyproline 
and hydroxylysine were present in all fractions. The tryp-
sin resistant GBM contained a much higher proline content 
than the other fractions, and contained no detectable hexose. 
All the other fractions, with the exception of one fraction 
from the peptide map of the papain digest, contained hexose. 
A great deal of the structural work on GBM has been 
done using bovine and canine sources of GBM. A main point 
of disagreement between various investigators seems to be 
whether or not a true collagen component is present in the 
GBM. Kefalides isolated a collagen component by limited 
digestion of canine GBM with Pronase at 4°c, pH 7.2 for 10.0 
h (21). This basement membrane "collagen" met the amino 
acid criteria for collagen, that is, glycine accounted for 
1/3 of the amino acid residues, while the sum of proline 
and hydroxyproline accounted for 20-22% of the amino acid 
residues. However, the presence of the characteristic 
triple helical structure consisting of three polypeptide 
chains was not observed. Kefalides attributed the lack of 
helical structure to the abnormally high carbohydrate con-
tent of the basement membrane collagen as compared to tendon 
collagen and stated: "Excess neutral hexose prevents la-
teral end to end aggregation so that the desired structural 
-5 
association with non-collagen glycoproteins is attaine~' 
( 2). Kefalides also theorizes: II • • • It is possible that 
collagen molecules exist at a low level of organization or 
that the association with the non-collagen like proteins 
interferes with the normal aggregative properties of the 
collagen and/or interferes with the staining procedures 
that bring about the periodic structure in electron micro-
scopy" (14).· Other characteristics of the GBM collagen 
isolated by Kefalides, as compared to tendon collagen, were 
higher levels of hydroxylysine, hydroxyproline, and neutral 
hexose ( 21). 
Kefalides determined the hexose content of the 
collagen to be 10% of the dry weight with glucose and 
galactose coristituting all of the hexose and being in ap-
proximately equimolar amounts (21). He found 95% of the 
hexose to be in a disaccharide unit composed of glucose 
and galactose while the other 5% consisted of the monosac-
charide galactose (2). Dische et al (9), using a hot TCA 
extraction, was able to extract a "collagen component" 
from human GBM and found carbohydrate associated with the 
collagen extract consisting of essentially galactose and 
glucose in a 4:3 ratio. Spiro (36) digested bovine GBM 
6 
with collagenase for 72 h followed by treatment of the sol-
ubilized material with Pronase. The soluble fraction was 
then submitted to gel filtration over Sephadex G-25. Two 
peaks were detected. The glycoproteins comprising the 
second peak yielded ten fractions upon chromatography on 
a Dowex 50 X-2 resin. All ten fractions and the original 
material from the second peak of Sephadex G-25 chromato-
graphy contained glucose, galactose, and hydroxylysine in 
equimolar amounts. The glucose and galactose formed a 
disaccharide linked to hydroxylysine in a struc.ture of 2-0-
o©-glucopyranosyl-0-P-n-galactopyranosylhydroxylysine (36). 
No mention was made of the isolation of a true collagen 
. 
like component and, therefore, the disaccharide moiety was 
not attributed as being on a "collagen" subunit. 
The void volume (first peak) recovered after fil-
tration over the Sephadex G-25 column was then passed over 
a Sephadex G-50 column. The group of glycopeptides which 
penetrated the G-50 column.contained sialic acid, galac-
tose, mannose, fucose, and hexosamine, but no glucose or 
hydroxyproline. Spiro deduced that the heteropolysac-
charide is linked to asparagine in the bovine polypeptide 
(36), an observation supported by Kefalides (14) for the 
-
-7 
heteropolysaccharide of canine GBM (see below). The void 
volume recovered after chromatography on Sephadex G-50 was 
composed of several glycopeptides containing all of the 
carbohydrates present in the native membrane (36). 
Following prolonged digestion of canine GBM with 
collagenase, Kefalides isolated insoluble and soluble frac-
tions (2). Further treatment of the insoluble fraction 
with reduction and alkylation in 8.0 M urea resulted in 
the isolation of large m. w. glycoprotein fraction in the 
void volume obtained after chromatography on Sephadex 
G-200. The glycoprotein fraction contained no hydroxy-
proline or hydroxylysine, but did contain a heteropoly-
saccharide composed of galactose, mannose, fucose, hexo-
samine, and sialic acid. 
The soluble fraction obtained after collagenase 
digestion of canine GBM contained a.small m. w. glycopro-
tein which penetrated the gel of Sephadex G-200. It had 
a m. w. of 30,000 dalt. and contained galactose, mannose, 
fucose, sialic acids, and twice as much hexosamine as the 
large m. w. glycoprotein (14). 
Kefalides proposed that the collagen component is 
linked to the small m. w. glycoprotein via disulfide bridges 
-8 
and that the complex was associated with the large m. w. 
glycoprotein via hydrogen and disulfide bonds. He based 
his proposal on (i) data concerning the solubility of GBM 
after treatment with 8.0 M urea or reduction and alkyla-
tion using mercaptoethanol and iodoacetamide, and (ii) the 
effect on GBM, as observed in electron microscopy, of re-
duction and alkylation using mercaptoethanol and iodoace-
tamide (2, 14). 
2. SCM. Extensive work on the chemistry and structure 
of the group A, type 12 SCM has not been reported. Freimer 
deduced that 85% of the SCM was composed of a lipoprotein 
complex (11). The membrane was found to contain 25% lipid, 
71% protein, and 2% carbohydrate, which he stated was 
"mainly glucose". Freimer also reported that the group 
A type 12 SCM contained 3.0% RNA, 1.0% phosphorous, 11.4% 
nitrogen, 19.1% lipid, and 1.9% glucose. Lange reported 
an amino acid analysis of the whole type 12 SCM, which 
is given in-Table 2 (25). 
Markowitz and Lange obtained a soluble fraction 
of group A, type 12 SCM(PGT-CM) following trypsinization 
and extraction with Genetron (29). PGT-CM was found to be 
• 
-Table 2. 
9 
Composition of the group A, type 12 strepto-
coccal cell membrane in mg/100 mg amino acids. 
Lysine 
Histidine 
Arginine 
Aspartic Acid 
Threonine 
Serine 
Glutamic Acid 
Praline 
Cysteic Acid 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Alloisoleucine 
9.1 
1.8 
4.4 
9.7 
5.4 
5.7 
12.6 
3.1 
0.1 
7.1 
15.7 
6.4 
0.6 
5.4 
7.0 
2.4 
3.3 
+* 
* "+" indicated presence of the amino acid in too low of 
a concentration to be calculated 
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80% protein, 7% carbohydrate, 3.7% phosphorous, and .2% 
hexosamine. PGT-CM contained no detectable sialic acid. 
The carbohydrate fraction of PGT-CM was composed of rham-
nose, ribose, glucose, galactose, glucosamine and galac-
tosamine. The molecular weight of PGT-CM was approximated 
to be 8,500 dalt. by utilizing ultracentrifugal data, 
behavior of PGT-CM in Sephadex G-75 chromatography, and 
amino acid analysis (29). 
If the chemical basis for the immunologic related-
ness of human GBM and group A, type 12 SCM is to be eluci-
dated, a great deal of biochemical analysis is still needed 
on the SCM and GBM. The bulk of the information in this 
short review on an actual structure for GBM has been con-
cerned with canine and bovine GBM; similar results have not 
been duplicated for human GBM. Moreover, very little is 
known about the primary chemical structure of the type 12 
SCM. 
However, elucidation of the chemical structures of 
the GBM and type 12 SCM is not the ultimate goal of this 
project. Here interest is directed as to why anti-SCM 
antisera react with GBM preparations in immunochemical 
tests and, conversely, why anti-GBM antisera react with 
11 
SCM.preparations in imrnunochemical tests, with the main 
goal being to see if affinity chromatography will provide 
a useful tool in this endeavor. 
B. Affinity Chromatography 
Affinity chromatography is a method of purifying 
a macromolecule on the basis of its biological or biochem-
ical function. One form of the method consists of covalently 
binding a biologically active protein to an insoluble matrix 
and passing over the affinity matrix a solution containing 
the macromolecule with the biological property of binding 
selectively and reversibly to the ligand attached to the 
insoluble matrix. The macromolecule is then eluted after 
all non-specific molecules have been washed out of the matrix. 
For enxyrne purification, the ligand may be a competitive 
inhibitor, coenzyrne, or substrate of the enzyme. Hormones 
can be purified in columns with their receptor proteins as 
ligands; and irnrnunoadsorbent columns contain either anti-
body or· antigen as ligand, depending on whether it is desired 
to purify antibody or to purify antigen. 
A good insoluble matrix would be composed of a 
polymer which interacts weakly with proteins in general to 
prevent non-specific adsorption, should possess chemical 
-12 
groups that can be activated or modified (in order to bind 
ligand) under conditions that would not alter significantly 
the structure of the matrix, should be stable to the con-
ditions involved in coupling the ligand and eluting the 
purified molecule, and finally should form a loose porous 
network which allows entry and exit of large macromolecules 
(31). Utilizing the above criteria, Sepharose (Pharmacia 
Fine Chemicals, Uppsala, Sweden) is an ideal matrix. Other 
commonly used insoluble polymers such as cellulose, starch, 
destran, and polyacrylamide usually have undesirable affin-
ities for the substance to be fractionated, which is pro-
bably due to carboxylic groups which lead to absorption via 
electrostatic attraction (31). 
Sepharose 4B is an insoluble matrix composed of 
spherical agarose gel beads with an exclusion limit of 
6 20 X 10 dalt. for proteins. Agarose is a linear polysac-
charide consisting of alternating residues of D-galactose 
and 3, 6 anhydro L-galactose units. The cyanogen bromide 
method (1) for the activation of Sepharose causes forma-
tion of cyclic and acyclic imidocarbonates by virtue of the 
reaction of CNBr with the hydroxyl groups of the Sepharose 
polymer. During the coupling of ligand to the CNBr acti-
... 
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vated Sepharose the ligand reacts through amino groups with 
the imidocarbonate to form mainly isourea derivatives (38). 
The purpose of an immunoadsorbent is to provide a 
quick and easy method for isolating specific antibody free 
of other serum proteins and of the antigen. The method 
has the advantage of isolating non-precipitating antibodies 
and antibodies in too low a concentration to be detected by 
classical precipitin techniques. Also, an immunoadsorbent 
may be used in the opposite sense; that is antibody specific 
for a certain antigen may be used as ligand on an immuno-
adsorbent for the isolation of antigen. 
To ascertain if the Sepharose immunoadsorbents will 
provide a tool in determining the structural basis for the 
immunologic relatedness between GBM and SCM, two parameters 
of the Sepharose immunoadsorbents must be investigated. 
First, the Sepharose immunoadsorbents must be capabie of 
isolating cross.-reactive antibody from heterologous sera 
for the antigen bound to the immunoadsorbent. The capability 
of the Sepharose immunoadsorbent to isolate cross-reactive 
antibody could be investigated by binding antigens of known 
chemical structure to Sepharose 4B, and passing samples of 
both homologous and heterologous sera over the immunoad-
-14 
sorbents. A comparison of the amount of antibody eluted 
and the antigenic specificity of eluted antibody from the 
two serum samples would give a good indication of the 
ability of the Sepharose immunoadsorbents to isolate cross 
·reactive antibody. 
Secondly, the effects of enzymatic digestion of 
antigen on the binding properties of the antigen to Sepha-
rose and subsequent binding of antibody to the Sepharose 
bound ligand must be compared to the same properties of _the 
antigen in its native form. To study this problem, an 
antigen of known chemical structure could be enzymatically 
digested (e.g.-trypsin, collagenase, sialidase), and bound 
to Sepharose. The binding properties of the enzyme treated 
antigen-immunoadsorbent would then be compared to the binding 
properties of a native antigen-immunoadsorbent. 
Knowledge of the properties of Sepharose concerning 
cross reactive antibody (and, therefore, cross reacting 
antigen) and enzymatically digested antigens could then be 
applied to GBM and SCM. Theoretically, various antigenic 
preparations of SCM and GBM may be used as ligands. The 
preparations would be prepared using various enzymes (tryp-
sin, pronase, collagenase, fucosidase). By passing various 
... 
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antisera prepared in rabbits against different SCM and GBM' 
antigenic preparations, antibody would be isolated specific 
for antigens on the SCM and GBM ligands. Also, anti-SCM 
sera could be passed over GBM-Sepharose irrununoadsorbents 
(or anti-GBM sera over SCM-Sepharose irrununoadsorbents) to 
isolate cross reactive antibody. Ultimately, the specific 
antibody would be bound to Sepharose, and the immunoadsor-
bent used to isolate antigen. Antigen isolated from various 
antibody-immunoadsorbents would then be isolated and com-
pared for chemical and structural relatedness. 
The problem arises that an antisera to a given 
protein or glycoprotein antigen consists of a mixed popu-
lation of antibodies with specificities for different 
antigenic determinants. Therefore, ideally the original 
antisera would be prepared against chemically well defined 
antigens, and the chemical compositions of the antigens 
used as ligand would also be well defined. A high degree 
of chemical characterization of the GBM and SCM antigenic 
preparations has not been attained yet. 
A goal of this research project will be to analyse 
the ability of Sepharose immunoadsorbent columns to quan-
titate the amount of antibody in a serum specific for the 
ligand on a particular Sepharose immunoadsorbent. The 
--
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method would consist of passing a given volume of antiserum 
over a Sepharose immunoadsorbent, and then determining the 
concentration of specific antibody eluted off the immunoad-
sorbent. The concentration would be calculated on the basis 
of the o. D. of the eluted fraction. Gill and Bernard, 
utilizing a BSA-bromoacetyl cellulose immunoadsorbent, used 
a spectrophotometric method to determine the concentration 
of anti-BSA antibody adsorbed from sera (13). Also, Wofsy 
and Burr, utilizing a para-aminophenyl-~-lactoside-Sepharose 
immunoadsorbent, used a spectrophotometric method to deter-
mine the concentration of anti-hapten antibody adsorbed 
from ascites fluid obtained from mice immunized with para-
azophenyl-P-lact~s ide-keyhole limpet hemocyanin (46). 
Other immunoadsorbents have been used in the past 
to determine specific antibody concentration in a given 
solution (6, 12, 18, 28, 30, 41, 42). However, the con-
centration of the purified antibody was usually determined 
utilizing classical precipitin techniques, which are (i) 
incapable of detecting non-precipitating antibody and (ii) 
destructive of the antibody being quantitated. 
Two requirements must be satisfied before the con-
centration of antibody in the eluted fraction is used to 
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determine the amount of specific antibody ih a given 
serum sample. First, saturation of column antigen sites 
must be avoided, a condition met only if the volume of 
the serum sample passed over the immunoadsorbent does not 
contain specific antibody in excess of available immuno-
adsorbent antigen sites. Therefore, specific antibody 
activ'ity should not be detectable in the effluent (composed 
of non-specific antibody and other serum proteins) fraction. 
Secondly, if the o. D. of the eluted fraction is to be used 
in the calculation of the antibody concentration, the eluted 
fraction must be free of serum proteins other than antibody. 
Initially, precipitin ring tests consisting of sam-
ples of the effluent fraction vs. a solution of the par-
ticular antigen involved will be used to detect specific 
antibody activity in the effluent fraction. The more sen-
sitive method of passive hemagglutination, utilizing antigen 
coated pyruvic aldehyde stabilized RBC (19), will also be 
used to detect specific antibody activity in the effluent 
fraction. 
There have been conflicting reports, both con-
firming (16, 47) and refuting (20) contamination with 
serum proteins of eluted fractions obtained from immunoad-
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sorbents. Therefore, immunoelectrophoresis will be used 
to determine if the antibody fraction eluted from the 
Sepharose imrnunoadsorbent is contaminated with other serum 
proteins. 
If the Sepharose irnmunoadsorbents provide a viable 
method for quantitating the amount of antibody in a serum 
specific for the ligand on a particular Sepharose irnmunoad-
sorbent, an explanation may be given for the titers in 
indirect fluorescent antibody tests obtained by Blue (3) 
of two anti-SCM and two and two anti-GBM sera. The SCM 
antisera were linearly diluted in one fold fashion and the 
GBM antisera diluted linearly in sixteen fold fashion. 
Each dilution was tested in indirect fluorescent antibody 
tests on untreated and carbohydrase (32) treated human 
kidney sections to obtain titers, the endpoint being the 
highest dilution showing a ± GBM fluorescence. If the 
concentrations of the antibody specific for GBM in the sera 
were determined, the question may be answered as to whether 
the difference in fluorescence on human kidney sections of 
antisera prepared against SCM and GBM antigen preparations 
is due to a difference in the size of a heterologous popu-
lation of antibody specific for various antigenic determinants 
... 
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on the GBM, or due to antibody of a relatively restricted 
heterogeneity with high affinity for a small number of 
antigenic sites. 
Recovery of activity of the isolated antibody from 
irrnnunoadsorbent columns will be investigated. A knowledge 
of the concentration of specific antibody in an antiserum 
would be useless unless knowledge of the loss of antibody 
activity due to the physical manipulation of the sample 
(i.e. elution, concentration, and reconstitution) is ob-
tained. To determine recovery of activity, the activity 
of the original antiserum in a given irrnnunological test 
must be compared to the activity of the eluted antibody 
fraction recovered from chromatography of the antiserum on 
an irrnnunoadsorbent. The method for measuring the activity 
should be easy to perform, rapid, and reproducible. Methods 
which were considered included a radioirrnnunoassay, micro-
complement fixation, and passive hemagglutination. Problems 
inherent to the method of the radioirrnnunoassay are the 
necessity for the construction of standard curves whenever 
an assay is run or new labelled protein preparations are 
used. Also, the methodology involved with the use of 
radioisotopes including handling, storage life of isotop-
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ically labelled protein, and the detection of label lessened 
the attractiveness of the method. For best results in the 
micro-complement fixation test optimum hemolysis of the 
sheep RBC must be determined, which necessitates deter-
. 
mination of optimum concentrations of sensitizing antibody 
for the sheep RBC, complement, and of the test antigen, 
procedures which would in all probability have to be re-
peated for each new combination of an antiserum and antigen 
used. Passive hemagglutination using pyruvic aldehyde 
stabilized RBC (19) seemed, therefore, to be the best 
method. The same ligand which is attached to a Sepharose 
immunoadsorbent may be attached to the activated RBC; the 
ligand bound cells can be stored for prolonged periods, 
and the original antiserum can be titrated the same day ~s 
the unknown sample thus providing a rapid and accurate means 
for comparison of activity. 
It is therefore proposed to investigate the ability 
of Sepharose 4B immunoadsorbents to isolate antibody both 
specific and cross reactive for the ligand attached to the 
immunoadsorbent, and to determine whether the immunoadsor-
bents are capable of providing a rapid method for quantita-
ting in antisera antibody specific for the ligand attached 
to the immunoadsorbent column. Sepharose 4B immunoadsorbents 
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will be constructed using as antigens BSA, HSA, BGG, RGG, 
HGG, protease, sialidase treated protease, and trypsin 
solubilized preparations of GBM and SCM. In addition, 
activity of the isolated specific antibody will be deter-
mined in passive hemagglutination assays. 
CHAPTER II 
MATERIALS AND METHODS 
A. Source of SCM 
Group A, type 12 SCM were isolated previously using 
the method of Markowitz and Lange (29). The insoluble 
membrane from treatment of separate samples of SCM with 
either sodium deoxycholate (Difeo, Detroit, MI), 2-chloro-
ethanol (Eastman, Rochester, NY), or Triton-X-100 (Eastman, 
Rochester, NY), were pooled and used as a source of SCM. 
B. Source of Kidneys 
Human autopsy kidneys were obtained from the 
Department of Pathology, Hines Veterans Hospital, Hines, 
Illinois. All kidneys were adjudged to be free of gross 
pathology and were from non-renal involved necropsies. 
C. Isolation of GBM 
Glomeruli were isolated by the method of Krakower 
and Greenspan (22). The cortices were separated from the 
medulla using a scalpel, and innnediately placed in cold 
phosphate buffered saline (PBS). The washed cortices were 
then pushed through steel wire mesh screening (100 mesh, 
F. P. Smith Cloth Co., Franklin Park, IL).with a spatula 
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into a container kept on ice. Cold PBS was added to resus-
pend the sediment, which was then centrifuged at 2,000 rev/ 
min for 3 to 4 min. The supernatant was decanted off and 
the sediment, which contained the glomeruli, was resuspended 
in PBS. The glomeruli were then washed and purified by 
allowing then to settle by gravity 3 to 4 times while 
washing with cold PBS. The purity of the glomerular pre-
paration was determined by the absence of epithelial cells 
under visualization with light microscopy. The suspensions 
were further washed until free of tubules and debris. Iso-
lated glomeruli were then washed with deionized water, 
pelleted by centrifugation and stored frozen until used 
for the isolation of GBM. 
GBM was isolated by the method of Krakower and 
Greenspon (22). Glomerular pellets were resuspended in 
PBS to a final concentration of 10% w/v. They were then 
sonicated at maximum intensity with a Branson sonifier, 
model S-75 (Branson Instruments Inc., Stamford, Connecticut) 
for 6 min. and checked with light microscopy to make cer-
tain that all glomeruli were disrupted. The sonicated 
material was centrifuged at 1,800 rev/min for 10 min. 
The resultant pellet contained the glomerular basement 
membrane. The GBM pellets were then washed twice in PBS 
.. 
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and once in deionized water, and centrifuged at 1,800 rev/ 
min for 10 min after resuspending the pellets. After being 
checked by microscopy for purity (i.e. absence of Bowman's 
capsule), isolated GBM was lyophilized, weighed, and stored 
for further use. 
D. Enzymatic Digestion of GBM, SCM, and Protease 
GBM and SCM were digested using bovine pancreas 
trypsin (Sigma Chemical Corp., St. Louis, MO). A weight 
ratio of 100/1 (mg membrane preparation/mg trypsin) was 
used for the digestion. The membrane preparation and tryp-
sin were mixed together in 0.07 M phosphate buffer, pH 8.1 
to a volume corresponding to 1.0 ml of buffer/10 mg of 
membrane to be digested. The solution was stirred inter-
. 0 
mittently for 6 h at 37 C, followed by stirring overnight 
at 4°C with a magnetic stirring bar. The solution was then 
centrifuged at 20,000 rev/min for 30 min. The supernatant 
was carefully decanted off, and dialyzed in 3,500 dalt. 
exclusion Spectrapor (Spectrum Medical Industries, Inc., 
Terminal Annex, Los Angeles, CA) membrane tubing against 
250 ml of deionized water for two days at 4°c, the deionized · 
water being changed each day. The contents of the membrane 
tubing were transferred to 8,000 dalt. exclusion Spectrapor 
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membrane tubing and again dialyzed for two days at 4°c 
against 250 ml of deionized water, with daily water changes. 
Finally, the contents of the membrane tubing were poured 
into a 10,000 dalt. exclusion dialysis tubing (Union Car-
bide, Chicago, IL) and dialyzed against deionized water 
. h 4°C. overnig t at The contents of the dialysis bag and 
the five 250 ml volumes were each lyophilized, weighed 
and stored. 
The pellet of insoluble GBM from the trypsin digest 
was washed in deionized water, resuspended in deionized 
water and lyophilized. The recovered trypsin resistant 
protein was then weighed and retrypsinized using the same 
procedure as above. The resultant trypsin resistant GBM 
was then digested with carbohydrase (32) using the same 
procedure used for the trypsin digestion with the following 
modifications. The carbohydrase-GBM mixture was placed in 
a piece of 10,000 dalt. exclusion dialysis tubing. The 
tubing was then placed in a graduate cylinder containing 
10.0 ml of PBS. After 6 h of digestion, the contents of 
the bag were poured into a 40.0 ml beaker, and trypsin was 
added directly to the mixture. The 10.0 ml of PBS from 
the graduate cylinder was tested for the presence of carbo-
• 
-
-26 
hydrate using the Molisch (15) test. The same dialysis 
and recovery methods used for the trypsin digest were used 
in handling of the carbohydrase-trypsin digest (tryp-carb-
sol-GBM). 
Protease, isolated by the method of Lange (24), 
was treated with neuraminidase (Sigma Chemical Corp., St. 
Louis, MO) to remove sialic acid. An amount of protease 
was dissolved in 0.1 M acetate buffer, pH 5.0, to yield a 
4.0 mg/ml solution. Substrate, acetate buffer, and enzyme 
were mixed in a 2/2/1 ratio and incubated for 1 h at 37°c. 
Percent release of sialic acid was determined by the direct 
Ehrlich method (45) by measuring the sialic acid content of 
the protease before and after digestion. 
E. DEAE Cellulose Chromatography 
Fractionation of trypsin solubilized GBM (greater 
than 10,000 dalt.) was performed on a 1 X 30 cm glass 
column containing a 10 ml bed volume of DEAE cellulose 
(Eastman, Rochester, NY). The DEAE cellulose was first 
equilibrated by passing 20 volumes (200 ml) of 0.005 M 
sodium phosphate buffer, pH 7.8 over the column; 100 mg 
of the sample was added in 5.0 ml of 0.005 M sodium phos-
phate buffer pH 7.8. 
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Elution was carried out sequentially using the 
following sodium phosphate buffers of increasing molarities 
and decreasing pH; 0.005 M, pH 7.8; 0.01 M, pH 6.1; 0.02 M, 
pH 7.0; 0.04 M, pH 6.0; 0.06 M, pH 5.0; 0.1 M, pH 5.0; and 
0.3 M, pH 4.0. All fractions were collected in 5.0 ml test 
tube amounts with a Fractomat (Buchler Company, Fort Lee, 
NJ) automatic fraction collector. Fractions were scanned 
at 280 nm and recorded on a Gilson tricorder. Appropriate 
0 tubes were pooled, dialyzed against deionized water at 4 C 
for three days, lyophilized and stored. 
F. Amino Acid Analyses 
Quantitative amino acid analyses of GBM prepara-
tions, SCM, GBM-Sepharose, BGG-Sepharose, and RGG-Sepharose 
were performed with a Beckman model 120C amino acid analyzer 
as previously described (23, 25, 29). Approximately 1.0 mg 
amounts of samples, or volumes of packed Sepharose theoret-
ically containing 1.0 mg amounts of protein, were hydro-
lyzed in evacuated test tubes containing 1.0 ml of 5.7 M 
0 
constant boiling HCl, at 110 C for 22 h. After hydrolysis, 
the tubes were opened and the contents dried over sodium 
hydroxide in a vacuum dessicator. Samples were solubilized 
with 2.2 ml of 0.2 N citrate buffer, pH 2.2 and duplicate 
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1.0 ml samples were placed on the short and long column, 
respectively. 
G. Antis era 
All of the SCM and GBM antisera utilized in this 
study were previously prepared in rabbits and tested for 
antigenic specificity (26, 27). Complete Freund's adjuvant 
was compo'sed of Marcol-52 (Humble Oil and Refining Cos.) 
containing lyophilized Mycobacterium tuberculosis strain 
H37Ra cells (2.5-5.0 mg/20 ml complete Freund's adjuvant), 
Falba (Pfaltz and Bauer, Inc., Flushing, NY), and PBS 
containing the particular antigen) in a ratio of 2:1:1. 
Initially, each rabbit received 2.0 mg of antigen in 
complete Freund 1 s adjuvant distributed in foot pads and 
subcutaneously in the neck. Fourteen days later, each 
animal was injected intramuscularly with 1.0 mg of antigen 
in incomplete Freund's adjuvant. One week after the last 
inoculation, the animals were exsanguinated. 
Twenty two antisera were prepared in 22 separate 
rabbits against seven chemically defined preparations of 
group A, type 12 SCM. The chemical treatments yielding 
soluble fractions of SCM included sodium lauryl sulfate 
(SLS-SCM), cyanogen bromide (CNBr-SCM), pepsin (Pep-SCM), 
-
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pepsin and CNBr (Pep-CNBr-SCM), and sodium lauryl sulphate 
and cyanogen bromide (SLS-CNBr-SCM) (27). Also, antisera 
were prepared against material from the second peak of 
DEAE cellulose chromatography of sodium lauryl sulphate 
solubilized SCM (SLS-SCM II), the insoluble SCM precipitate 
following pepsin digestion of SCM (Pep-Insol-SCM), and 
whole insoluble SCM(SCM). 
Six glomerular preparations are represented by 
ten antisera. The antisera were prepared against GBM 
solubilized by treatment with sodium lauryl sulfate and 
cyanogen bromide (SLS-CNBr-GBM); material from the second 
and third peaks of DEAE cellulose chromatography of glom-
eruli (GLOM) solubilized by treatment with Genetron and 
trypsin (PGT-HuGlom II and PGT-HuGlom III); insoluble, 
trypsin resistant GBM (Tryp-Res-GBM); whole glomeruli 
(HuGlom); and whole GBM (HuGBM). 
Other antisera included equine anti-whole rabbit 
serum (anti-WRS, from Kallestad Laboratories, Minneapolis, 
MN), goat anti-rabbit gamma globulins (anti-RGG, supplied 
by Dr. Lange); sheep anti-human serum albumin (anti-HSA, 
supplied by Dr. Lange) and anti-human light chain of IgG 
(anti-HLC, supplied by Dr. Lange); and rabbit anti-bovine 
F' 
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serum albumin (anti-BSA, supplied by Dr. Lange), anti-human 
ganuna globulin (anti-HGG, supplied by Dr. Lange), anti-
bovine gamma globulin (anti-BGG, supplied by Dr. Lange), 
anti-goat gamma globulin (anti-GGG, from Kallestad Labor-
atories, Minneapolis, MN), and anti-human urinaryo<1-acid 
glycoprotein (an~i-proteose, supplied by Dr. Lange). 
Normal rabbit serum (NRS) and normal sheep serum (NSS) 
were each a pool of preimmunization bleedings supplied 
by Dr. Lange. 
H. Affinity Columns 
The method of Cuatrecasas (7) was used for the 
activation of Sepharose 4B (Pharmacia Fine Chemicals Inc., 
Piscataway, NJ) with CNBr (Eastman Kodak, Rochester, NY). 
A slurry of Sepharose-4B was allowed to settle, the water 
decanted off the surface of the packed gel, and the gel was 
resuspended in 10 volumes of deionized water. The process 
was repeated several times in order to remove the "fines" 
and also the sodium azide preservative. After the final 
wash, the volume of the packed gel was estimated and an 
equal volume of deionized water was added. For every ml 
of settled Sepharose-4B, 100 mg of CNBr was used in the 
activation step. The appropriate amount of CNBr was dis-
31 
solved in a volume of deionized water equal to that of the 
Sepharose slurry. The pH of the Sepharose slurry was ad-
justed to 11 •. 0 by the addition of 4.0 M NaOH, and the CNBr 
solution was added. While stirring with a glass rod, the 
pH was monitored and held at 11.0 by the addition of 4.0 M 
NaOH dropwise with a Pasteur pipette. Once the pH remained 
at 11.0 without further addition of base (approximately 10-
15 min at room temperature) the activation step was complete. 
The activated gel was washed with 20 volumes of cold 
0.1 M bicarbonate buffer, pH 8.65 on a Buchner funnel, and 
resuspended in 0.05 M phosphate buffer pH 7.5 up to a volume 
equal to that of the original Sepharose slurry. The ligand 
(S.O mg/1.0 ml packed Sepharose) was quickly added in an 
amount of 0.05 M phosphate buffer, pH 7.5 corresponding to 
5-15% of the final volume of the Sepharose-ligand mixture. 
The test tube containing the mixture was then placed on a 
rotating circular test tube rack for end over end mixing 
0 
at 4 C for 24 h. The coupled gel was washed with 0.05 M 
phosphate buffer pH 7.5 on a fine sintered glass filter. 
The wash was dialyzed against deionized water for 3 d at 
4°c with daily water changes and lyophilized to obtain the 
dry weight of the unbound ligand, a value which was then 
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used for the determination of the amount of ligand which 
had attached to the gel. The gel was washed four to five 
times with alternate 50.0 ml volumes of 0.1 ~ borate buffer, 
pH 8.5 and 0.1 M sodium acetate buffer, pH 4.0. 
Approximately 5.0 ml of the completed gel was 
poured into a glass column (1 X 15 cm) over a 1.0 cm glass 
wool plug, with a filter paper disc separating the gel from 
the glass wool. Several volumes of 0.05 M sodium phosphate 
buffer, pH 7.5 were passed over the column prior to the 
addition of the sample of antiserum until a baseline was 
established on the Gilson recorder. After the entire volume 
of antiserum had entered the gel, phosphate buffer was con-
tinuously added to the column until it became apparent from 
the recorder that the effluent had passed through the column. 
Elution of the bound protein was carried out with the frac-
tion collector collecting approximately 6.0 ml/test tube 
volumes. To check for saturation with antibody of the avail-
able antigen sites on the column, each tube comprising the 
effluent fraction was observed for precipitation with a 3.0 
mg/ml sample of antigen in precipitin ring tests. Tubes 
comprising the effluent and eluted fractions were pooled 
separately. The O.D. of the eluted fraction was in some 
33 
cases determined on a Hitachi Perkin Elmer Model 139 UV-VIS 
spectrophotometer (Tokyo, Japan) at 280 nm, in order to 
gain an initial estimate of the antibody concentration. 
The fractions were then dialyzed against deionized water 
0 for 3 d at 4 C and lyophilized. 
The lyophilized samples were reconstituted in a 
volume of borate buffered saline (BBS), pH 8.0, corres-
ponding to the original volume of the serum sample. The 
o. D. of the eluted fraction was determined for an estima-
tion of its antibody content. 
Antigens coupled to Sepharose included: BSA 
(Sigma Chemical Co., St. Louis, MO); BGG and HGG (Pentex 
Inc., Kankakee, IL); HSA and RGG (supplied by Dr. Lange): 
proteose, neuraminidase treated proteose, trypsin solubi-
lized GBM (greater than 10,000 dalt.), and trypsin solubi-
lized SCM (greater than 10,000 dalt.). 
I. Irrnnunoelectrophoresis 
Immunoelectrophoresis of selected eluted antibody 
fractions was performed with 1.5% Ionagar (Colab, Chicago 
Heights, IL) gels on glass slides with a Gelman (Gelman 
Instrument Co., Ann Arbor, MI) immunoelectrophoresis appa-
ratus. Electrophoresis of the antigens (1.0 mg/ml solutions 
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of eluted antibody fractions in BBS) was run for 100 min 
at 30 mA and 100 volts in 0.10 M barbital buffer, pH 8.6. 
The undiluted antisera were added and immunodiffusion 
carried out for 38 h in a moist chamber ut room temperature. 
The slides were then washed 2 d in saline followed by wash-
ing for 2 d in deionized water. 
After drying, the gels were stained with Napthalene 
Black 12B (Allied Chemical and Dye Corporation, New York, 
NY) in methanol, glacial acetic acid, and water (5:2:5), 
and then destained in a solution -0f methanol, glacial acetic 
acid, and water (7:1:2). 
J. Hemagglutination Assays 
Type o, Rh negative human erythrocytes and rabbit 
erythrocytes were stabilized and tanned by the method of 
Hirata (19). The 1.0% RBC solution was distributed in 3.0 
ml volumes into 5.0 ml glass vials, frozen in a dry ice and 
0 
acetone bath, and stored at 0 C. After a vial of cells 
was thawed, antigens were adsorbed to the surface of the 
RBC by the addition of 3.0 ml of a 0.1% solution of the 
test antigen (O.l M acetate buffer, pH 3.5) to 27.0 ml of 
stabilized erythrocytes (in the same acetate buffer). The 
final concentration of the RBC was 1.0%. The mixture was 
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incubated at 37°C, with gentle stirring, for 1 h. The cells 
were then washed in.10.0 mlof0.11 M sodium phosphate buffer, 
pH 7.2 five times by centrifuging at 1,000 rev/min for 15 
min between each wash. After the final ·wash, the cells were 
resuspended in phosphate buffer to a volume yielding a 1.0% 
solution, and stored at 4°C. For determining titers, 1.0 
ml of the 1.0% solution was diluted in phosphate buffer to 
a volume yielding a 0.25% solution. 
Antigens coupled to cells include BSA, HSA, RGG, 
BGG, HGG, protease, neuraminidase treated protease, tryp-
sol-SCM (greater than 10,000 dalt.), tryp-sol-GBM (greater 
than 10,000 dalt.), tryp-carb-sol-GBM, DEAE Fraction I of 
tryp-sol-GBM, and tryp-sol-GBM (3,500-8,000 dalt.). 
The titer of each antiserum and the titers of the 
reconstituted effluent and eluted fractions from passage 
of the antiserum over an antigen-Sepharose column were 
determined simultaneously (in duplicate) using Cooke Engine-
ering Co. (Alexandria, VI) Microtiter equipment. In addi-
tion, a volume of each eluted fraction was diluted with an 
equal volume of NRS and titers of each antiserum and matched 
effluent and NRS diluted eluted fractions were determined 
in duplicate~ Titers are reported as the reciprocal of the 
... 
36 
highest dilution showing visible hemagglutination; and an 
approximation of the log2 of the titer was also recorded. 
K. Production of Hemorrhagic Necrosis in Guinea 
Pigs Using Anti-SCM and Anti-GBM Antisera 
A single guinea pig was bled from the heart in 
order to obtain erythrocytes for use in slide agglutination 
tests and absorption of antisera. The guinea pig blood was 
centrifuged at 2,000 rev/min for 10 min, washed with PBS 
and centrifuged again at 2,000 rev/min for 20 min. The 
pellet, representing approximately 2.0 ml of guinea pig 
RBC, was resuspended to a final volume of 10 ml in PBS. 
Slide agglutination tests were performed by placing 
a drop of the guinea pig RBC suspension and a drop of an 
antiserum on a slide (all antisera were first inactivated 
at 60°C for 3 min). The two drops were then mixed with a 
wooden applicator stick. All "+" agglutinating antisera 
were then absorbed with guinea pig RBC by adding two volumes 
of packed cells to each volume of antisera. The absorbed 
antisera were again checked with the slide agglutination 
test, and if still positive, were reabsorbed with guinea 
pig RBC. 
The backs of guinea pigs were shaved and 0.1 ml 
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of antiserum was injected subcutaneously into one of five 
sites on the back of each guinea pig (four different anti-
sera/guinea pig, with NRS in the middle of the back of 
each animal) followed approximately one min later by the 
injection of 0.1 ml of epinephrine (1.0 mg/ml) adjacent 
to each site. Responses were observed after 24, 48, 72, 
96, and 120 h. All necrotic lesions were measured, by 
measuring the length and width of each lesion as uniformly 
as possible, and also by taking Kodak Ektachrome-X(ASA 64) 
color slides using a Kodak Instamatic camera. Responses 
were graded as+ (definite redness), 2+ (lesion 10 X 10 nun), 
3+ (lesion 15 X 15 nun), and 4+ (lesion greater than 20 X 
20 MM). 
L. Fluorescent Antibody Tests 
Indirect fluorescent antibody tests (43) were done 
on human kidney cortex sections using effluent and eluted 
fractions from affinity chromatography of a rabbit anti-
PGT HuGlom II serum. A 5.0 ml sample of the serum was 
passed through a column of trypsin solubilized GBM 10,000 
dalt.-Sepharose. After elution, the effluent fraction was 
passed through the column again. After dialysis and lyo-
philization, the effluent fraction was reconstituted to its 
--
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original volume, of 5.0 ml with BBS. One ml of this pre-
paration was then used to reconstitute the pooled eluted 
fractions. 
Kidney cortex sections were sliced 2 microns (u) 
thick. Two sections were evaluated/slide. On each slide 
a sample of antiserum, effluent or eluted antibody fraction, 
NRS, or saline were overlayed on the sections and incubated 
at room temperature for 45 min. The slides were then washed 
3 times in PBS, for 10 min/wash. The slides were dried by 
pressing between paper towels and then overlayed with a 
1:40 dilution of fluorescein conjugated sheep anti-rabbit 
garrnna globulin which had been absorbed with charcoal powder 
(previously prepared). The slides were incubated for 30 
min at room temperature in a moist chamber and then washed 
and dried as described above. Sections were mounted with 
cover slips in 90% glycerol, 10% PBS and observed with a 
Leitz Wetzlar (E. Leitz, Inc., Rockleigh, NJ) fluorescence 
microscope for glomerular staining. All fluorescent anti-
body slides were read by 3 independent viewers to confirm 
gradations of reactivities. 
... 
CHAPTER III 
RESULTS 
A. Isolation of GBM 
From sixteen human autopsy kidneys, approximately 
39.3 gm (wet weight) of whole glomeruli were isolated, 
which yielded 1.2 gm (dry weight) of GBM. 
B. Enzyme Digestions 
Initially, 500 mg of human GBM was d~gested with 
5.4 of trypsin in 50 ml of 0.07 M phosphate buffer, pH 8.1. 
From this, 179.0 mg of insoluble material was recovered, 
while the soluble fraction contained 156.4 mg of material, 
over 10,000 dalt., 5.0 mg of 8,000-10,000 dalt. material, 
and 42.0 mg of material with 3,500-8,000 dalt. Total re-
covery was 382.4 mg, representing a 76.5% recovery of the 
starting material. 
The 179.0 mg of trypsin resistant GBM was retryp-
sinized, by 1.79 mg of trypsin in a volume of 18.0 ml of 
0.07 M phosphate buffer, pH 8.1. The insoluble fraction 
contained 137.5 mg of ma~erial; and the soluble fraction 
contained 20.0 mg of material over 10,000 dalt., 1.1 mg 
of material 8,000-10,000 dalt., and a trace of material 
39 
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of 3,500-8,000 dalt. Total recovery was 158.6 mg, represen-
ting 88.6% recovery of the starting material. 
The 117.0 mg sample of resultant trypsin resistant 
GBM was digested with 1.0 mg of carbohydrase in 10.0 of 
PBS. The Molisch test, performed as described in Materials 
and Methods, was negative. After 6 h, the dialysis bag was 
opened, and 1.0 mg of trypsin was added to the digestion. 
Following the additive digestion, 70.8 mg of insoluble 
material and 9.1 mg of soluble material, over 10,000 dalt. 
were recovered, representing a 68.3% recovery of the 
starting material. 
Total recovery of material from all enzymatic 
treatments of GBM resulted in 91.3 mg of insoluble GBM 
and 233.65 mg of soluble material, representing a 70% 
recovery of the starting material. 
A 200 mg pool of separate samples of SCM previously 
extracted by treatment with either sodium deoxycholate, 
2-chloroethanol, or Triton X-100 was digested with 2.0 mg 
of trypsin in 20.0 ml of 0.07 M phosphate buffer, pH 8.1. 
Following this, 48.6 mg of SCM greater than 10,000 dalt. 
was recovered, representing a 24.3% recovery of the starting 
material. 
,. 
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A 36.4 mg sample of proteose was digested with 
sialidase after which 29.4 mg of material was recovered. 
The direct Ehrlich's method (45) was used to determine 
the sialic acid content of the starting materia1 (9.4 mg/ 
100 mg). After the direct Ehrlich's method was used to 
determine the sialic acid content of the digested material 
(1.68 mg/100 mg), it was determined that 82.1% of the sialic 
acid was cleaved from the proteose preparation. 
c. DEAE Cellulose Chromatography of Trypsin Soluble 
GBM 
Tubes from the appropriate fractions, as determined 
by examination of the recorded ultraviolet absorption peaks 
(Fig. 1), were pooled, dialyzed against distilled water, 
and lyophilized. Fraction I yielded 15.9 mg of material, 
Fraction II, 7.55 mg, Fraction III, 4.3 mg, and Fraction IV, 
13.2 mg. Thu~ approximately 40% of the starting material 
of 100 mg was recovered. 
D. Amino Acid Analyses 
Table 3 contains data for the amino acid composi-
tion of the fractions resulting from the digestion of SCM 
and GBM by trypsin and also for the trypsin solubilized GBM 
)10,000 dalt. Sepharose innnunoadsorbent. Table 4 contains 
data for the amino acid composition of GBM-Sepharose, RGG-
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Fig. 1. DEAE cellulose chromatography of trypsin 
solubilized GBM, of m. w. greater than 10,000 dalt. +' N 
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Sepharose, and BGG-Sepharose. 
Amino acid analysis recorded in Table 3 revealed 
the absence of hydroxylysine and hydroxyproline in SCM. 
Half-cystine was the amino acid in lowest concentration 
(1.62 mg/100 mg), while glutamic and aspartic acids were 
in the highest concentration (16.7 and 14.3 mg/100 mg, 
respectively). Hexosamine was present in the trypsin 
solubilized SCM>l0,000 dalt. fraction. 
All GBM fractions obtained by trypsin digestion of 
whole GBM contained hydroxylysine and hydroxyproline, as 
recorded in Table 3. With the exception of the 10,000 
fraction, hydroxyproline was the amino acid of highest 
concentration in the GBM fractions (trypsin resistant GBM-
14.9 mg/100 mg, )3,500(8,000-16.4 mg/100 mg, >8,000(i0,000-
15.1 mg/100 mg). Glycine was the amino acid of highest 
concentration (14.4 mg/100 mg) in the ~10,000 fractions. 
In general, glycine and hyroxyproline were the two amino 
acids of highest concentration in all the GBM fractions. 
Glutamic acid was also uniformly of high concentration in 
all GBM fractions. Methionine was the amino acid of lowest 
concentration in two of the GBM fractions (trypsin resistant 
GBM-0. 91 mg/100 mg, )8, 000(10, 000-0. 79 mg/100 mg). In the 
r .. f. 
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)3,500(8,000 and )10,000 fractions, half-cystine (0.95 mg/ 
100 mg) and histidine (1.33 mg/100 mg) were the respective 
amino acids in lowest concentration. Hexosamine was present 
in all CBM fractions except the trypsin resistant fraction. 
When comparing the amino aci.d analysis of the tryp-
sin sblubilized GBM )10,000 fraction to the amino acid 
analysis of the homologous Sepharose immunoadsorbent recor-
ded in Table 4, no amino acid was present in an equivalent 
concentration. As a possible explanation for this discre-
pancy, perhaps a select population of molecules from the 
original antigen population were preferentially bound to the 
Sepharose, thus changing the mg/100 mg contribution of in-
dividual amino acids. Since protein molecules theoretically 
bind to Sepharose throughE-amino groups of their lysine 
residues (1), the higher concentration of lysine in the 
irmnunoadsorbent (4.47 mg/~00 mg), as compared to the ori-
ginal antigen preparation (2.00 mg/100 mg) is in agreement 
with this theory. 
As recorded in Table 4, significant differences 
(±5%) in umol/100 umol concentration of amino acids occur 
between unused and used samples of the GBM immunoadsorbent 
(histidine, arginine, glutamic acid, alanine, valine, and 
methionine), between unused and used samples of the RGG 
--
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immunoadsorbent (lysine, aspartic acid, threonine, serine, 
proline, alanine, valine, methionine, leucine, tyrosine, 
and phenylalanine), and unused and used samples of the BGG 
immunoadsorbent (histidine, arginine, aspartic acid, serine, 
proline, half-cystine, glycine, valine, methionine, iso-
leocine, leucine, and tyrosine). There were gross differ-
ences between mg protein/ml gel between used and unused 
preparations of the RGG irnrnunoadsorbent (.0.91 mg) and the 
BGG irnmunoadsorbent (1.58 mg). The difference in mg pro-
tein/ml gel for the GBM irnrnunoadsorbent was slight (0.04 mg). 
The values for mg protein/ml gel of unused Sepharose pre-
parations recorded in Table 4 for GBM-Sepharose (0.26), RGG-
Sepharose (0.70), and BGG-Sepharose (1.44) differ consi-
derably from the mg protein/ml gel recorded in Table 5 for 
GBM-Sepharose (1.83), RGG-Sepharose (4.63), and BGG-Sepha-
rose (4. 34). 
E. Affinity Columns 
Initial work with the affinity columns concerned 
the feasibility of developing a method for the determination 
in sera concentrations of antibody specific for the antigen 
bound to the column. Ten ml volumes of Sepharose were 
coupled with RGG, BGG, HSA, and BSA antigens. Table 5 
Table 3. Composition of SCM and GBM preparations in mg/100 mg amino acids. 
Amino Acid 
Lysine 
Hydroxylysine 
Histidine 
Arginine 
Aspartic Acid 
Hydroxyproline 
Threonine 
Serine 
Glutamic Acid 
Praline 
Half Cystine 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Amide-nitrogen* 
Hexosamine 
Trypsin 
solubilized 
SCM 
10,000 dalt. 
4.28 
1.77 
2.98 
14.3 
5.74 
4.66 
16.7 
4.02 
1.62 
5.10 
6.29 
6.73 
1.77 
7.42 
9.87 
3.58 
5.10 
0.309 
+ 
* Reported as urnol/190 urnol · 
**,Off scale 
Trypsin 
resistant 
·GEM 
2.12 
2.07 
1.43 
6.56 
7.96 
14.9 
2.94 
4.04 
11.5 
8.15 
1.77 
14.2 
5.66 
1.84 
0.91 
2.88 
6.1 
1.96 
3.34 
0.62 
)3,500 dalt. 
<B,ooo 
4.02 
2.18 
2.91 
6.52 
9.58 
16.4 
3.16 
3.54 
10.4 
4.80 
0.95 
11.2 
4.36 
1.54 
3.8 
3.68 
5.86 
1.86 
3.28 
0.18 
+ 
Trypsin solubilized GBM 
>8,ooo d lt :>10,000 dalt. 
<10,000 a • ')-10,000 dalt. Sepharose 
2.68 
3.52 
2.68 
6.00 
9.37 
15.1 
3.76 
4.15 
11.4 
. 5. 30 
0.921 
15.8 
3.54 
2.65 
0.79 
2.60 
5.50 
1.44 
2.68 
0.194 
+ 
2.00 
3.20 
1.33 
3.93 
6.9 
12.4 
6.53 
3.64 
11.0 
5.44 
1.60 
14.4 
5.19 
2.85 
1.49 
4.04 
7.25 
2.58 
4.17 
0.234 
+ 
4.47 
2.93 
1.66 
8.22 
9.98 
15.9 
3 .02 
4.82 
16.0 
8.64 
0.84 
0.5 
3.62 
3.95 
1.32 
4.69 
8.45 
1.47 
4.89 
0.5 
+ 
~ 
°' 
Table 4. Composition of antigen-Sepharose 4B preparations in 
urnol/100 urnol amino acids. 
Antigen Description Trypsin Solubilized RGG BGG 
GBM>l0,000 dalt. 
Column Designation Unused used Unused Used Unused Used 
Amino Acid 
Lysine 3.78 3.59 7.89 5.61 5.26 5.00 
Hydroxylysine 2.19 2.39 
Histidine 1.31 1.93 1.12 0.91 0.64 1.87 
Arginine 6.67 3.63 3.06 3 .12 3.48 2.91 
Hydroxyproline 15.4 15.8 
Aspartic Acid 9.29 8.49 9.87 7.78 8.75 7.09 
Threonine 4.67 5.44 8.52 7.50 11.4 11.94 
Serine 5.69 6.68 9.55 18.2 12. 5 10.1 
Glutamic Acid 13.4 11.8 12.6 13.3 9.92 10.4 
Proline 9.29 8.42 7.01 5.33 7.30 8.43 
Half Cystine 0.42 0.69 2.36 2.18 2.11 1.75 
Glycine O.S.* O.S.* 7.06 7.01 7.96 9.58 
Alanine 5.97 9.46 8.27 10.8 6.56 6.04 
Valine 4. 20 5.44 6.07 7.46 9.22 7.68 
Methionine 0.65 0.35 0.80 0.18 1.00 0.80 
Isoleucine 4.43 4.28 2.39 2.10 2.48 3.16 
Leucine 7.98 7.68 7.48 5.64 6.34 7.26 
Tyrosine 1.03 0.89 2.42 1.89 2.40 4.14 
Phenylalanine 3.64 3.01 3.27 2.07 2.31 2.28 
mg antigen/ml gel 0.26 0.30 0.70 1.61 1.44 3.02 
* Off Scale +' 
-....J 
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lists the umol of antigen theoretically bound to the Seph-
arose during the coupling stage for RGG, BGG, HSA, BSA, and 
the other antigens coupled to Sepharose for use in the 
project. 
The three immunoglobulin Sepharose immunoadsorbents 
showed the highest binding of antigen during the coupling 
· stage, with HGG having essentially all of the added ligand 
(5.0 mg/ml) bound during the coupling stage. The least 
amount of antigen bound to any one column was 0.32 mg/ml 
on the proteose #1 immunoadsorbent. Of those antigens for 
which more than one column was made (BSA, proteose, siali-
<lase treated proteose), the BSA immunoadsorbents gave the 
best reproducibility in binding (BSA #1, 1.37 mg/ml and BSA 
#2 1.08 mg/ml) while the two proteose immunoadsorbents 
displayed the wprst reproducibility in binding (proteose 
#1, 0.32 mg/ml and proteose #2, 1.54 mg/ml). Of note was 
the equivalent amount of antigen bound for GBM 10,000 dalt. 
(1.83 mg/ml) and SCM 10,000 dalt. (1.84 mg/ml). 
Figure 2 is a typical "run" of an antiserum over 
an affinity column, with effluent and eluted fractions 
labelled appropriately. By obtaining the o. D. of the 
reconstituted eluted fraction, and knowing the initial 
Table 5. Quantity of antigen bound to Sepharose 
4B columns 
50 
Antigen Antigen bound/ml packed 
BSA #1 
BSA #2 
HSA 
BGG 
RGG 
HGG 
Protease #1 
Protease #2 
Sialidase treated 
Sialidase treated 
prote·ose 
protease 
Trypsin solubilized GBM 
>10,000 dalt. 
Trypsin solubilized SCM 
>10,000 dalt. 
Sepharose 4B 
umol (mg) 
0.02 (1.37) 
0.02 (1.08) 
0.04 (2.90) 
0.03 (4.34) 
0.03 (4.63) 
0.03 (5.00) 
0.01 (0.32) 
0.04 (1.54) 
#1 0.03 (1.27) 
#2 0.05 ( 2.14) 
(1.83) 
(1.84) 
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volume of antiserum added to the column, one could theore-
tically obtain a reasonable value for the concentration in 
the serum of the antibody specific for the antigen coupled 
to the Sepharose. No consistent attempt was made to measure 
the o. D. of the eluted fraction inunediately after its 
collection due to the large volume (12-20 ml) of the frac-
tion and the subsequent questionable results which were 
often obtained. Data recorded in Table 9 on protein con-
centrations of eluted fractions depict the problem (compare 
final concentrations vs. concentrations determined at elu-
tion). The extinction coefficient for RGG was determined 
experimentally using known concentrations of RGG isolated 
by DEAE Sephadex chromatography. Unfortunately, the data 
for the experiments was collected over a period of months. 
In that time span, it was discovered that the spectrophoto- . 
meter was not giving consistent readings. As a result, a 
Beckman Spectrophotometer Model DUR (Beckman Instruments, 
Inc., Fullerton, CA) had to be used for some of the readings. 
As a ·consequence of these mechanical difficulties, the 
values reported in Table 6 are not and cannot be considered 
true representations of antibody concentrations in sera. 
However, those data listed as being obtained on the same 
--
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date are of value in reporting relative antibody concentra-
tion between samples, since they were determined under iden-
tical experimental conditions. 
Inconsistent results· were obtained for concentra-
tions of antibody in eluted fractions from experiments in-
volving passage of successive equal volumes of antiserum 
over the same gel bed. Examples are two successive runs 
of 1.0 ml of anti-RGG serum over RGG-Sepharose (4/22/76), 
yielding 1.47 mg/ml and 2.34 mg/ml; and two .successive 
runs of 1.0 ml of anti-BGG serum over BGG-Sepharose 
(6/14/76), yielding 0.27 mg/ml and 0.60 mg/ml. Inconsis-
tent results were also obtained from experiments in which 
successive runs of increasing volumes of antisera were 
passed over the same innnunoadsorbent. Examples are: anti-
RGG serum over the RGG-Sepharose, 1/29/76 (1.0 ml-1.97 mg/ 
ml, 1.5 ml-2.34 mg/ml) and 1/30/76 (2.0 ml-2.52 mg/ml, 3.0 
ml 2.04 mg/ml); sheep anti-HSA serum over HSA-Sepharose, 
4/16/76 (2.0 ml-1.02 mg/ml, 3.0 ml-1.78 mg/ml) and 5/19/76 
(1.0 ml-2.04 mg/ml, 2.0-1.5 mg/ml); anti-BGG serum over 
BGG-Sepharose, 4/29/76 (1.0 ml-0.36 mg/ml, 2.0 ml-0.56 
mg/ml); and finally anti-HLC serum over HGG-Sepharose, 
5/10/76 (1.0 ml-0.48 mg/ml, 5.0 ml-0.57 mg/ml). 
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Fig. 2. Typical affinity chromatogram. Figure depicts 
successive runs of 0.5, 1.0, and 2.0 ml of a rabbit anti-BGG serum 
over a BGG-Sepharose 4B column. Note run through (effluent) and 
eluted fractions. 
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Table 6. 
Golumn 
Antigen 
RGG 
HSA 
BGG 
HGG 
BSA 
54 
Antibody concentrations of eluted fractions 
from affinity chromatography of antisera on 
Sepharose 4B antigen columns. 
Antiserum 
Rabbit 
anti-
RGG 
Sheep 
anti-
HSA 
Rabbit 
anti-
BGG 
Rabbit 
anti-
HGG 
Rabbit 
anti-
HLC 
Rabbit 
anti-
BSA 
Date 
1/29/76 
1/29/76 
1/30/76 
1/30/76 
4/22/76 
4/22/76 
1/ 9/76 
4/16/76 
4/16/76 
5/19/76 
4/29/76 
4/29/76 
6/14/76 
6/14/76 
6/14/76 
5/10/76 
5/10/76 
5/10/76 
11/21/75 
11/26/75 
12/ 6/75 
12/10/75 
Volume( ml) 
1.0 
1.5 
2.0 
3. o-i:* 
1.0 
1.0 
2.0 
3.0 
2.0 
1.0 
2.0 
1.0 
1.0 
2.0 
1.0 
1.0 
5.0 
9. 0*1i: 
14.0** 
5. 0*"'' 
5.0** 
Eluted Antibody 
Concentration"'' 
1.97 
2.34 
2.52 
2.04 
1.47 
2.34 
1.77 
1.02 
1.78 
1.51 
0.36 
0.56 
0.27 
0.60 
0.58 
0.90 
0.48 
0.57 
2.64 
1.53 
2.81 
1.80 
*In mg/ml of the original volume of sera passed over 
the column. 
**Indicates precipitation in ring tests of the effluent 
fraction vs. antigen ' 
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Data obtained from experiments involving passage 
of an anti-BSA serum over the BSA-Sepharose innnunoadsorbent 
was obtained on different days. The problems mentioned in 
Section H of Materials and Methods concerning the spectro-
photometer had not occurred at the time the data was col-
lected. Therefore, the eluted antibody concentration 
obtained for the four experiments using the same BSA-
Sepharose gel bed and the same anti-BSA serum are compar-
able to each other. The concentrations are: 11/21/75, 
9.0 ml-2.64 mg/ml; 11/26/75, 14.0 ml-1.53 mg/ml; 12/6/75, 
5.0 ml-2.80 mg/ml; and 12/10/75, 5.0 ml-1.88 mg/ml. 
Precipitin ring tests of the effluent fraction of each 
experiment vs. BSA were positive. 
1. Determination of Specificity of Eluted Antibody. In 
ring tests, goat anti-RGG serum precipitated with the 
eluted fractions of rabbit antisera and ring tests consis-
ting of the eluted fraction vs. a solution of the antigen 
coupled to the respective Sepharose column also resulted 
in precipitation. 
As another test of the specificity of the eluted 
antibody, 5.0 mg samples of anti-BSA antibody, isolated 
from the previous affinity column runs of a rabbit anti-BSA 
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serum over BSA-Sepharose columns, were dissolved in 5.0 
ml of phosphate buffer, pH 7.5. Duplicate samples were 
run over BSA-Sepharose columns and HSA-Sepharose columns. 
The results are shown in Figs. 3A and 3B. Determinations 
of antibody concentrations using O. D. were not attempted; 
instead the number of squares under each curve were tabu-
lated and reported in Table 7. 
Passage of the anti-BSA solution over the BSA-
Sepharose immunoadsorbent resulted in the following areas 
under curves: Fig. 3A. effluent peak 1-78, eluted peak 
1-1096; effluent peak 2-75, eluted peak 2-894. Passage of 
the anti-BSA solution over the HSA-Sepharose immunoadsor-
bent resulted in the following area under curves: Fig. 3B. 
effluent peak 1-1195, eluted peak 1-201; effluent peak 
2-1067, eluted peak 2-307. Total area under curves in 
Fig. 3A was 2143 square units; under curves in Fig 3B was 
2770 square units. 
2. Effect of the Removal of Sialic Acids from Proteose 
Antigen on the Binding of the Antigen to Sepharose. Com-
parison of Affinity Chromatography Using Proteose-Sepharose 
and Proteose(sialidase treated)-Sepharose Columns. Siali-
dase treated protease and untreated protease were bound to 
r . 
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Table 7. Evidence for the specificity of antibody in 
eluted fractions from affinity chromatogra-
phy of antisera. Comparison of areas under 
curves resulting from affinity chromatogra- · 
phy of 1.0 mg/ml solutions in PBS of anti-
BSA antibody isolated from affinity chroma-
tography of an anti-BSA serum over BSA-
Sepharose columns. 
Curve Designation Area Under Curve* 
Eluted Fraction 
Fig. 3. (A. BSA-Sepharose) 
Peak 1. 1096 
Peak 2. 894 
Fig. 3. (B. HSA-Sepharose) 
Peak 1. 201 
Peak 2. 307 
Effluent Fraction 
Fig. 3. (A) 
Peak 1. 78 
Peak 2. 75 
Fig. 3. (B) 
Peak 1. 1195 
Peak 2. 1067 
*l square = 1 square unit 
0.5 
i 
d" 
0 
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Fig. 3A. Result of passing successive 5.0 ml samples 
of a 1.0 mg/ml solution of anti-BSA antibody in 0.5 M phosphate 
buffer, pH 7.5 over a BSA coupled Sepharose 4B affinity column. 
U1 
(X) 
Fig. 3B. Result of passing successive 5.0 ml samples 
of a 1.0 mg/ml solution of anti-BSA antibody in 0.05 M phosphate 
buffer, pH 7.5 over a HSA coupled Sepharose 4B affinity column. 
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separate 10.0 ml volumes of packed Sepharose. The exper-
iment was done in duplicate, and the umol of antigen bound/ 
ml of packed Sepharose for each column are given in Table S. 
Relative antibody concentrations of eluted fractions from 
experiments in which samples of the same rabbit anti-
proteose serum were passed over the columns are given in 
Table 8, along with theoretical combining ratios of antibody 
with column antigen sites. 
The data is divided into two groups, I and II, 
since the removal of sialic acids by treatment of protease 
with sialidase was not determined for the antigen prepara-
tion used in construction of the sialidase-proteose #1 
Sepharose immunoadsorbent. However, the digestion was 
carried out in exactly the same manner as the digestion of 
the protease used for sialidase-proteose #2, of which the 
% release of sialic acids was reported in Section B of 
this chapter. Since the protease for both digestions was 
obtained from the same batch of material, the sialic acid 
content of the two preparations would not be expected to 
differ significantly. In addition, data for sialidase 
protease #1 and protease #1 were obtained on the same day, 
while the data for sialidase protease #2 and protease #2 
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were obtained on a different day. Therefore, a compari-
son between the figures of the two sections is not valid. 
However, in both groups of data, combining ratios for the 
proteose-Scpharose immunoadsorbcnts (Protease #1: .081 
and .076 umol antibody/umol antigen; Proteose #2: .017, 
.021, and .017 umol antibody/umol antigen) were greater 
than combining ratios for proteose(sialidase treated)-
Sepharose immunoadsorbents (Sialidase-Proteose #1: .024 
and .011 umol antibody/umol antigen; Sialidase-Proteose 
#2: .013 and .011 umol antibody/umol antigen). Referring 
to Table S, the umol of antigen bound to the proteose-
Sepharose immunoadsorbents (Proteose #1-0.03 umol/ml gel, 
Proteose #2-.01 umol/ml gel) is less than the umol of an-
tigen bound on proteose(sialidase treated)-immunoadsorbents 
(sialidase treated proteose #1-0.04 umol/ml gel, sialidase 
treated proteose #2-0.03 umol/ml gel). 
F. Analysis of Eluted Fractions Utilizing Immunoelec-
trophoresis. 
Fig. 4 depicts results of immunoelectrophoresis 
of the eluted fractions resulting from affinity chromato-
graphy of rabbit anti-BSA and goat anti-RGG sera over 
homologous antigen-Sepharose columns. · 
Table 8. Comparison of affinity chromatography of a rabbit 
anti-protease serum on proteose-Sepharose and 
proteose(sialidase treated)-Sepharose columns. 
···~~-""''~~·~Pliif\UJ#M Jjj ·~ 
Colu11ll1 Description Serum Sample 
Volume(ml) 
I.** 
Sialidase-proteose #1 5.0 
Sialidase-proteose #1 5.0 
Proteose #1 5.0 
Proteose #1 5.0 
II. 
Sialidase-proteose #2 1.0 
Sialidase-proteose #2 3.0 
Proteose #2 1.0 
Proteose #2 2.0 
Proteose #2 3.0 
*Expressed as mg/ml of the original antiserum 
**% release of sialic acid not. determined 
Eluted Antibody 
Concentration* 
0.54 
0.24 
0.61 
0.57 
0.41 
0.49 
0.52 
0.64 
0.50 
Combining Ratio 
(umol antibody/ 
umol antigen) 
.024 
.011 
.081 
.076 
.011 
.013 
.017 
.021 
.017 
0\ 
N 
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A single precipitin arc was observed between anti-
WRS (trough #3) and a sample of a pool of all eluted anti-
BSA fractions (well B) recorded in Table 6. Since the arc 
is in a corresponding position to the precipitin arc 
between anti-WRS (trough #3) and RGG (well C), the eluted 
antibody fraction from affinity chromatography on the BSA 
immunoadsorbents is composed solely of RGG. Further proof 
is provided by the equivalent pattern of precipitin arcs 
(each pattern composed of two arcs) between anti-RGG 
(trough #2) and the pooled eluted anti-BSA fraction (well 
B); and between anti-RGG (trough #4) and RGG (well C). 
The precipitin arcs formed between anti-WRS (trough #1) 
and NRS (well A), and between anti-RGG (trough #2) and NRS 
(well A) are included for reference. 
The absence of a precipitin arc between anti-RGG 
(trough #4) and the eluted goat anti-RGG fraction tends 
to lessen the likelihood that column bound antigen was 
shed during the elution step on the RGG immunoadsorbent •. 
It should be noted that the goat anti-RGG serum was passed 
over a RGG-Sepharose imnrunoadsorbent, and that the RGG used 
in the construction of the column is from the same source 
as the RGG present in well c. A precipitin arc was also 
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Well: A B c D 
Trough: 1 2 3 4 5 
Fig. 4. Inununoelectrophoresis of eluted antibody 
fractions from affinity chromatography of rabbit anti-BSA 
and goat anti-RGG sera over homologous antigen-Sepharose 
columns. Well: A. NRS, B. eluted anti-BSA, C. RGG 
(identical arttigen preparation coupled to Sepharose), 
D. eluted anti-RGG. Trough: 1. anti-whole rabbit serum 
(WRS), 2. anti-RGG, 3. anti-WRS, 4. anti-RGG, 5. artti-GGG. 
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formed between anti-GGG (trough #5) and the eluted goat 
anti-RGG fraction (well D). 
G. Determination of Antibody Activity in Effluent 
and Eluted Fractions Using Hemagglutination Assays. 
With the use of antigen coated RBC it was possibl~ 
to (i) provide a more sensitive method than the ring test 
for determining antibody saturation of antigen sites by 
comparing the titer of the effluent fraction to the titer 
of the original serum; and (ii) determine if the observed 
decrease in hemagglutinating activity observed in the ef-
fluent fraction could be accounted for by a corresponding 
increase in antigen specific hemagglutination activity in 
the eluted fraction. Data are recorded in Tables 9, 10, 
11, 12, 13, 14, 15, and 16. Double dashed lines indicate 
a titer was not determined; a 11 011 indicates a titer of O. 
When observing Tables 9-16, the reader must give 
careful consideration for titers of standard serums (i.e. 
a titer of the serum from which the original sample run 
over the affinity column was obtained) when interpreting a 
given set of figures. Not all of the titers were determined 
on the same day or on the same batch of antigen coated RBC. 
The term "serum affinity sample" shall refer to the effluent 
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and eluted fractions collectively, when discussing the 
number of linear twofold dilutions carried out on the 
effluent and eluted fractions. 
Data for titers was also reported in log2 of the 
dilution. A decision was made to report the titers by 
this method after it was decided that the reciprocal of 
the dilution was not the best method for comparing the 
hemagglutination activity of effluent and eluted titers. 
For example, suppose a serum has a hemagglutination titer 
of 32,000. After passing a volume of the serum over an 
affinity column, the effluent fraction was determined to 
have a titer of 8,000 and the eluted 4,000. From compar-
ison of the titers reported as reciprocals of dilutions, 
it may appear that a great deal of hemagglutinating acti-
vity has been lost. However, the log2 of the dilution of 
the original serum is 5, meaning that a L:l,000 dilution 
of serum had to be serially diluted out in twofold fashion 
5 times before all hemagglutinating activity disappeared. 
Using the same reasoning, the effluent fraction was diluted 
out twice, indicating that again a fivefold dilution of 
the serum was necessary to remove the hemagglutinating ac-
tivity. Therefore, the log2 of the sample dilution pre-
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sents a more accurate description of the hemagglutinating 
activity of the effluent and eluted fractions. 
As a specific example, the titer of the standard 
serum on the batch of HSA coated RBC used to titer the 
2.0 ml sample from 4/16/76 recorded in Table 9 was 28,800. 
This means that a 1/1,000 dilution of the serum was dilu-
ted in twofold fashion approximately 4.75 times (log2 
16,000 = 4, log2 32,000 = 5) to obtain the titer. The 
titers of the effluent and eluted fractions of the 4/16/76 
sample were 5,600 (2.5) and 3,200 (1.5) respectively. 
Therefore, a total of four twofold dilutions were needed 
to obtain a titer on a 1/1,000 dilution of the serum 
affinity sample. The titer of the standard serum on the 
batch of HSA coated RBC usedcto titer the NSS reconsti-
tuted eluted fraction of the 2.0 ml sample from 4/16/76 
was 18,000, roughly equivalent to a 1/1,000 dilution of 
the serum being diluted out four times. The titers of the 
effluent (800, .5) and NRS reconstituted eluted (3,200, 
1.5) fractions indicate that effectively a 1/1,000 dilution 
of the serum affinity sample was diluted in twofold fashion 
twice to obtain the titer (.5 + 1.5 = 2). Therefore, the 
titers determined on non-reconstituted eluted and respec-
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tive effluent fraction from the 2.0 ml sample from 4/16/76 
show a better recovery of hemagglutinating activity (4/4.75) 
as compared to the NSS reconstituted eluted fraction and 
respective effluent fraction (2/4). 
However, the two serum affinity samples from 
5/19/76 which were NSS reconstituted, show a greater re-
covery of hemagglutinating activity than the respective 
non-reconstituted serum affinity samples (NSS reconstituted: 
1.0 ml-2/4, 2.0 ml-4/4; non-reconstituted: 1.0 ml-1.57, 
2.0 ml-4.5/7). For the 3.0 ml sample from 4/16/76, both 
the non-reconstituted (6.5/4.75) and NSS reconstituted 
(6/4) serum affinity samples show a higher hemagglutinating 
activity than the respective standard serums. This pro-
bably represents an error of reconstituting the eluted 
antibody in too small of a volume of BBS, effectively 
concentrating the antibody and thereby increasing the 
titer of the eluted fraction. 
Of note in Table 12 was the vast improvement in 
recovery of hemagglutinating activity shown in the NRS 
reconstituted serum affinity samples from 4/29/76 over the 
respective non-reconstituted fractions (NRS reconstituted: 
1.0 ml-2.5/4, 2.0 ml-4.5/4; non-reconstituted: 1.0 ml-
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1.5/9, 2.0 ml-1/9). Once again, a slight error in recon-
stituting the eluted antibody fraction of the 2.0 ml sample 
may have occurred (or possibly when reconstituting with 
NRS), indicating the importance of precise technique when 
reconstituting the fractions. NRS reconstituted serum 
affinity samples of the goat anti-RGG serum from 5/22/76 re-
corded in Table 14 show a similar improvement in recovery 
of hemagglutinating activity over, non-reconstituted frac-
tion (NRS reconstituted: I. 1.0 ml-3/3, II. 1.0 ml-2/3; 
non-reconstituted: I. 1.0 ml-.5/5.5, II. 1.0 ml-.5/5.5). 
All NRS reconstituted affinity samples recorded in Table 15 
displayed improvement in recovery of hemagglutinating ac-
tivity over non-reconstituted fractions, both for the goat 
anti-RGG serum samples from 5/22/76 (NRS reconstituted: I. 
1.0 ml-2/3.5, II. 1.0 ml-4.75/3.5-possibly another recon-
stitution error; non-reconstituted: I. 1.0 ml-.5/2.5, 
II. 1.0 ml-.5/2.5) and the anti-BGG serum from 5/23/76 
(NRS reconstituted: 8/9.5; non-reconstituted-2.5/5). 
In those instances previously mentioned where errors 
were made in reconstitution of eluted antibody fractions 
(3.0 ml from 4/16/76 in Table 9, 2.0 ml from 4/29/76 in 
Table 12, II. 1. 0 ml from 5/ 22/76 in Table 15), with the 
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exception of the serum affinity sample of 3.0 ml from 
4/16/76 recorded in Table 9, it is doubtful that the in-
crease in hemagglutinating activity of the NRS reconstituted 
eluted fraction over the non-reconstituted eluted fraction 
could be explained on the sole basis of the slight error 
that may have been made during reconstitution (either with 
BBS of the original lyophilized material or NRS of the 
buffered eluted antibody solution). The NRS (also NSS in 
Table 9) used to reconstitute buffered eluted fractions 
never contributed significantly to the titer of the recon-
stituted eluted fractions, as shown by titers recorded in 
all tables containing data on hemagglutination assays (with 
the exception of Table 16, since the effluent fraction was 
used to reconstitute the eluted antibody). 
The high titers (as compared to standard serums) 
of effluent fractions recorded in Table 13, for both NRS 
reconstituted.and non-reconstituted serum affinity samples, 
indicate that the RGG-Sepharose preparation was a very poor 
immunoadsorbent. Of note is the essentially complete re-
covery of hemagglutinating activity in non-reconstituted 
serum affinity samples from 1/30/76 (3.75/3.75), 1/31/76 
(3.75/3.75) and the 1/5 ml sample from 1/29/76 (3.25/3.75). 
r 
--
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The respective NRS reconstituted serum affinity samples 
displayed a slight decrease in recovery of hemagglutinating 
activity (1/30/76: 5/6, 1/31/76: 5/6, 1.5 ml sample from 
1/29/76: 5/6). 
Data recorded in Table 16 demonstrate the result 
of concentrating the eluted antibody fraction during the 
buffer reconstitution step. Increases in titers were ob-
served in all eluted fractions (as compared to standard 
serums) assayed on the various antigen preparations with 
the exception of the assay on trypsin-carbohydrase solubi-
lized GBM >10,000 dalt. coated RBC (on which no titer for 
the standard serum, effluent, or eluted fractions was 
observed). Examples are: trypsin solubilized GBM >3,500 
<8,000 dalt. coated RBC (eluted: 20,800/standard serum: 
3,584), DEAE fraction I of trypsin solubilized GBM >10,000 
dalt. coated RBC (eluted: 260/standard serum: 148), and 
trypsin solubilized GBM >10,000 dalt. coated RBC (eluted: 
1,040/standard serum: 416). 
It was found that RGG and BGG could only be coupled 
to rabbit RBC, since attempts to couple RGG and BGG to 
human RBC always resulted in preparations that autoagglu-
tinated. Also, it was necessary to use the supernatant 
--
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resulting from the first attempt at coupling rabbit RBC 
with RGG or BG9 to couple a second batch of cells, since 
the first preparation invariable autoagglutinated. HGG 
and SCM were not successfully coupled to either human or 
rabbit RBC. HGG preparations autoagglutinated; SCM pre-
parations never demonstrated a titer with any SCM or GBM 
antiserum used (including the eluted fraction from the GBM 
serum described in section L of Materials and Methods). 
All antigen coated cells were stored at 4°c. Antigen 
coated cells which were frozen and then thawed for use 
in assays consistently autoagglutinated. 
H. Fluorescent Antibody Tests. 
Comparison of indirect fluorescent antibody tests 
revealed that the concentrated eluted fraction of the anti-
PGT HUGL II serum gave more intense glomerular staining 
than the original serum. Of additional proof of effective-
ness of the trypsin solubilized GBM >10,000 dalt. inununo-
adsorbent was the finding that the glomerular staining 
intensity of the effluent fraction was comparable to NRS 
and normal saline controls, indicating complete removal of 
specific antibody from the serum. 
I. Production of Hemorrhagic Necrosis in Guinea Pigs. 
Table 9. 
Identification 
Inununoadsorbtion of sera on a HSA coupled Sepharose 
4B column. The assessment of recovery of antibody 
activity as measured by hernagglutination of HSA 
coated erythrocytes. 
Protein concentration of Hernagglutination Titer 
eluted fraction (mg/ml) 
Serum: Sheep-anti-HSA NSS Reconstituted 
Volume Date At elution Final Effluent Eluted Effluent Eluted 
5. 0 ml 1/ 9/76 1.80 
-- -- --
400 2,560 
(l)* 
1.0 ml 4/16/76 1.48 ... -
2. 0 ml 4/16/76** 0.80 1.02 5,600 3,200 800 3,200 
( 2. 5) (1. 5) (. 5) (1. 5) 
3.0 ml 4/16/76** 0.68 1.78 8,400 12,800 3,600 16,640 
( 3) ( 3. 5) ( 2) (4) 
1. 0 ml 5/19/76*** 1.88 2.04 1,600 1,300 1,800 1,600 
(1) (. 5) (1) (1) 
2. 0 ml 5/19/76*** 1.27 1.51 6,400 4,200 800 13,440 
( 2. 5) ( 2) (. 5) (3. 5) 
*Number in parenthesis indicates logt of the dilution of the given sample 
**Titer of standard serum = 128,000 ( ) 
***Titer of standard serum= 28,800 (4.75) 
For all NSS reconstituted fractions, the titer of the standard serum was 18,000 (4). 
The NSS had a titer of 4. 
.. ~ 
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Table 10. Immunoadsorbtion of sera on a pr~t:':~:,-:=·-w;"'*'¥\llJ4iiiC!J ~ 
Sepharose 4B column. The assessment of recovery 
Identification 
of antibody activity as measured by hemagglutination 
of proteose coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml) 
Hemagglutination Titer 
Serum: Rabbit-anti NRS Reconstituted 
proteose 
Volume Date At elution Final Effluent* Eluted* Effluent Eluted 
I. 
5.0 ml 1/15/76 -- • 61 8 40 40** 1,680?';-* 
(1) 
II. 
5.0 ml 1/15/76 . • 57 32 40 40** 3 360** --
' (1. 5) 
1.0 ml 5/12/76 1.33 .695 -- -- 40*** 60--;':7:* 
2.0 ml 5/12/76 1.08 .654 
-- --
640,~** 420*'"''~ 
1.0 ml 6/21/76 1.19 .52 
-- --
520*;\-* 2' 56Q;\-** 
(1. 5) 
2.0 ml 6/21/76 1.99 .64 
-- --
560*** 3 200*** 
' (1. 5) 
3.0 ml 6/21/76 1.43 .so -- -- 420*** 3' 200*;\-* (1. 5) 
*Titer of standard serum = 500 
**Titer of standard serum = 16,000 (4) 
**;\-Titer of standard serum = 52,000 (5.5) 
Titer of NRS = 2 
Note: Erythrocytes used in the NRS reconstituted series were coated 
t.1H-h sia1 idase treated proteose. 
-.....! 
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Table 11. 
Identification 
Immunoadsorbtion of sera on a proteose (sialidase tre~ted) 
coupled Sepharose 4B column. The assessment of recovery 
of antibody activity as measured by hemagglutination of 
proteose (sialidase treated) coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml) 
Hemagglutination Titer 
Serum: Rabbit-anti- NRS Reconstituted 
Proteose 
Volume Date At elution Final Effluent* Eluted* Effluent Eluted 
I. 
5.0 ml 1/16/76 0.54 0 20 
II. 
5.0 ml 1/16/76 0.24 0 20 
1.0 ml 5/11/76 
Column #2 
1.0 ml 6/23/76 0.82 0.49 
-- --
3.0 ml 6/23/76 0.68 0.41 
-- --
*Titer of standard serum = 500, using non-sialidase treated glycoprotein 
coated erythrocytes. 
**Titer of standard serum = 16,000 (4) 
***Titer of standard serum= 5,200 (2) 
Titer of NRS = 2 
40** 
20** 
640*-1:* 
1,280*** 
(. 5) 
420** 
1,040** 
(. 5) 
120** 
180~'>"*-l~ 
8QQ1\-*1\"' 
(. 5) 
'-1 
V1 
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Table 12. 
Identification 
Immunoadsorbtion of sera on a BGG coupled Sepharose 
4B colurrm. The assessment of recovery of antibody 
activity as measured by hemagglutination of BGG 
coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml) 
Hemagglutination Titer 
..,,... 
Serum: Rabbit-anti-BGG NRS Reconstituted 
Volume Date 
0.5 ml 4/29/76 
1.0 ml 4/29/76 
2.0 ml 4/29/76 
1.0 ml 6/12/76 
1.0 ml 6/14/76 
2.0 ml 6/14/76 
At elution 
4.04 
6.14 
4.16 
*Titer of standard serum = 512,000 (9) 
**Titer of standard serum = 16,000 (4) 
***Titer of standard serum = 52,000 (5.5) 
Titer of NRS = 4 
Final 
0.36 
0.56 
0.27 
0.60 
0.58 
Effluent* Eluted* Effluent Eluted 
16 
1,280 
(. 5) 
2,600 
(1. 5) 
800 
(. 5) 
90** 20** 
80** 6 720** 
' ( 2. 5) 
140*** 20 800*** 
' 
1, 600;~** 
(1) 
800;~** 
(. 5) 
1, 6007'"** 
(1) 
(4. 5) 
1, 600;~** 
(1) 
1, 60071"** 
(1) 
'-l 
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Table 13. 
Identification 
Im.-nunoadsorbtion of sera on a RGG coupled Sepharose 
4B column. The assessment of recovery of antibody 
activity as measured by hernagglutination of RGG 
coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml 
Hernagglutination Titer 
Serum: Goat-anti-RGG NRS Reconstituted 
Volume Date At elution 
3. 0 ml 1/30/76 
2.0 ml 1/31/76 
1.0 ml 1/29/76 
1. 5 ml 1/29/76 
1. 0 ml 4/22/76 
1. 0 ml 4/22/76 4.00 
*Titer of standard serum= 14,400 (3.75) 
**Titer of standard serum = 64,400 (6) 
Titer of NRS = 20 
Final 
2.04 
2.52 
1.97 
2.37 
1.47 
2.34 
Effluent* Eluted* Effluent** Eluted** 
10,640 
(3.25) 
10,640 
( 3. 25) 
10,440 
(3.25) 
800 
(. 5) 
800 
(. 5) 
400 
800 
32,000 
(5) 
32,000 
(5) 
32,000 
( 5) 
0 
640 
116 
0 
-...J 
-...J 
Table 14. 
Identification 
Serum: Goat-anti-RGG 
Column Antigen: BGG 
Volume Date 
I. 
1.0 ml 5/22/76 
II. 
1.0 ml 5/22/76 
Serum: Rabbit-anti-BGG 
Column Antigen: RGG 
1.0 ml 5/23/76 
Irrnnunoadsorbtion of sera on RGG and BGG coupled Sepharose 
4B columns. The assessment of recovery of antibody activity 
as measured by hemagglutination of RGG coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml) 
Hemagglutination Titer 
NRS Reconstituted 
At elution Final 
2.11 
2.25 
0.88 
Effluent* Eluted* Effluent**Eluted** 
400 520 
400 560 
20 16 
4,760 
( 2. 5) 
3,360 
(1. 5) 
0 
720 
(. 5) 
1,120 
(. 5) 
0 
*Titer of RGG standard serum = 52,000 (5.5); of BGG standard serum= 1,280 (.5) 
(3); of BGG standard serum= 160 **Titer of RGG standard serum = 10,640 
Titer of NRS = 16 
"-J 
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Table 15. 
Identification 
Serum: Goat-anti-RGG 
Colurrm Antigen: BGG 
Volume Date 
I. 
1.0 ml 5/22/76 
II. 
1.0 ml 5/22/76 
Serum: Rabbit-anti-BGG 
Colurrm Antigen: RGG 
1.0 ml 5/23/76 
Immunoadsorbtion of sera on RGG and BGG coupled Sepharose 
4B columns. The assessment of recovery of antibody activity 
as measured by hemagglutination of BGG coated erythrocytes. 
Protein concentration of 
eluted fraction (mg/ml) 
At elution Final 
2.11 
2.25 
0.88 
Hemagglutination Titer 
NRS Reconstituted 
Effluent* Eluted* Effluent**Eluted** 
800 
800 
6,400 
( 2. 5) 
20 
20 
20 
2,240 
(1) 
3,360 
(1. 5) 
16,640 
(4) 
3,072 
(1. 5) 
7,168 
( 2. 7 5) 
16,640 
(4) 
*Titer of RGG standard serum= 5,600 (2.5); of BGG standard seru.~ = 36,000 (5) 
**Titer of RGG standard serum= 13,440 (3.5); of BGG standard serum= 832,000 (9.5) 
Titer of NRS = 8 
-....J 
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Table 16. 
Antigen Description 
Irnmunoadsorbtion of an anti-GBM serum on a GBM coupled 
Sepharose 4B colurrm. The assessment of recovery of 
antibody activity as measured by hemagglutination of 
erythrocytes coated with various GBM antigens. 
Anti-PGT HuGlom II Effluent* 
Trypsin-Carbohydrase solubilized 
GBM >10,000 dalt. 
0 0 
Trypsin solubilized GBM 
>3,500<8,000 dalt. 
DEAE Fraction I of Trypsin 
solubilized GBM 
>10,000 dalt. 
Trypsin solubilized GBM 
>10,000 dalt. 
3,584 678 
148 0 
416 2 
*Originally 5.0 ml of anti-PGT HuGlom II was passed over a Sepharose colurrm 
coupled with trypsin solubilized GBM 10,000 dalt. The effluent was run 
through the column again. The resulting effluent fraction and pooled 
eluted fractions were dialyzed and lyophilized as described in section H 
of Materials and Methods. The effluent fraction was reconstituted to 5:0 ml 
in BBS, 1.0 ml of which was then used to reconstitute the pooled eluted 
fractions. 
Eluted'~ 
0 
20,800 
260 
1,040 
00 
0 
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Results of the production of hemorrhagic necrosis 
in guinea pigs using anti-GBM and anti-SCM sera are recorded 
in Table 17. 
The antiserum causing the strongest necrotic reac-
tion was anti-SCM #25, which caused a 4+ reaction from 
24h-120h. Other antisera causing strong (at least one 4+ 
reaction during the course of the experiment) necrotic 
reactions include trypsin res. GBM #14, CNBr-SCM-super #18, 
PGT-HuGlom II #20, SCM #26, SLS-SCM II #28, SCM #29, and 
Pep. Insol. SCM #30. Antisera causing no visible necrotic 
reaction were HuGlom #11 and Pep-CNBr-SCM #15. Other anti-
sera causing weak (only a + reaction during the course of 
the experiments) necrotic reactions include HuGBM #1, SLS-
GBM #2, PGT-HuGlom III #5, SLS-CNBr-GBM #6, PGT-HuGlom III 
#7, CNBr-SLS-SCM #9, SLS-SCM #10, SLS-CNBr-GBM #13, SLS-SCM 
II #22, and SCM #23. NRS caused a positive reaction in one 
animal, G. P. I(+ at 72 hand 96h). 
Antisera against the same antigen preparation and 
causing varying degrees of necrosis include Pep-CNBr-SCM 
#3 (G. P. I: 3+ at 120h) and #15 (G. P. IV: no reaction); 
SLS-SCM #4 (G. P. I: 3+ at 120h), #10 (G. P. III: +at 
72h), and #17 (G. P. V: 3+ at 120h); HuGlom #8 (G. P. II: 
• 
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3+ at 120h), and #11 (G. P. III: no reaction); and SLS-
SCM II #22 (G. P. VII: + at 120h) and #28 (G. P. VII: 
4+ at 120h). Antisera against the same antigenic prepar-
ation causing similar severity of necrosis include: PGT-
HuGlorn III #5 (G. P. II: + at 120h) and #7 (G. P. II: 
+at 96h); SLS-CNBr-GBM #6 (G. P. II: +at 120h), #12 
(G. P. III: 2+ at 96h), and #13 (G. P. IV: +at 120h); 
CNBr-SLS-SCM super #21 (G. P. VII: 3+ at 72h) and #27 
(G. P. VII: 3+ at l~Oh); and Pep. Insol. SCM #24 (G. P. 
VIII: 3+ at 120h) and #30 (G. P. VIII: 4+ at 120h). 
The seven anti-SCM sera caused the following reactions, 
given in order of increasing severity: #23 (G. P. VIII: 
+at 120h), #19 (G. P. VI: 2+ at 120h), #20 (G. P. II: 
2+ at 120h), #16 (G. P. IV: 3+ at 120h), #26 (G. P. VI: 
4+ at 120h), #29 (G. P. VIII: 4+ at 120h), and #25 (G. P. 
VI: 4+ at 120h). 
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Table 17. Production of hemorrhagic necrosis in guinea 
pigs using anti-SCM and anti-GBM antisera. 
Animal # Site # Antiserum 24h 48h 72h 96h 120h 
-----
I NRS + + 
1 HuGBM #1 + + 
2 SLS-GBM #2 + 
3 Pep-CNBr-SCM #3 + + + 3+ 
4 SLS-SCM #4 + 2+ 2+ 3+ 
II NRS 
1 PGT-HuGlom III #5 + + + 
2 SLS-CNBr-GBM #6 + 
3 PGT-HuGlom III #7 + 
4 HuGlom #8 + 2+ 2+ 2+ 3+ 
III NRS 
1 CNBr-SLS-SCM super #9 + + + 
2 SLS-SCM #10 + 
3 HuGlom #11 
4 SLS-CNBr-GBM #12 + + 2+ 
IV NRS 
1 SLS-CNBr-GBM #13 + + + 
2 Trypsin res. GBM #14 4+ 4+ 3+ 
3 Pep-CNBr-SCM #15 
4 SCM #16 2+ 3+ 3+ 3+ 
v NRS 
1 SLS-SCM #17 3+ 2+ 2+ 3+ 
2 CNBr-SCM super #18 + 2+ 2+ 4+ 2+ 
3 SLS-CNBr-SCM #19 + 3+ 3+ 3+ 3+ 
4 PGT-HuGlom II #20 + 4+ 4+ 4+ 3+ 
VI NRS 
1 SCM #19 2+ 
2 SCM #25 4+ 4+ 4+ 4+ 4+ 
3 SCM #20 + 2+ 2+ 2+ 2+ 
4 SCM #26 4+ 
VII NRS 
1 CNBr-SLS-SCM super #21 + 3+ 2+ 2+ 
2 CNBr-SLS-SCM super #27 + 2+ 3+ 3+ 3+ 
3 SLS-SCM II #22 + 
4 SLS-SCM II #28 + + 2+ 2+ 4+ 
VIII NRS 
1 SCM #23 + + + + 
2 SCM #29 2+ 4+ 4+ 4+ 
3 Pep Insol. SCM #24 2+ 3+ 3+ 3+ 
4 Pep Insol. SCM #30 + + 4+ 4+ 4+ 
CHAPTER IV 
DISCUSSION 
Classical precipitin techniques for the quantita-
tion of specific antibody in sera are (i) wasteful of sera, 
(ii) incapable of detecting non-precipitating antibody and 
(iii) destructive of the antibody being quantitated. With 
the advent of the use of the immunoadsorbents for the iso-
lation of antibody (28)·, in theory it became possible to 
quantitate the concentration of antibody without destroying 
it since the antibody is obtained free of iti? antigen and, 
there,fore, recoverable for further immunological tests. 
Methods used for the creation of immunoadsorbents have 
included derivatives of cellulose (6, 12, 28, 41, 42), 
polystyrene (39), polyacrylamide (20), and soluble antigen 
precipitated by chemical means (18, 30). The physical 
characteristics of Sepharose make it a superior choice in 
the construction of immunoadsorbents over previously re-
ported methods. 
Sepharose 4B immunoadsorbents were investigated 
for their ability to quantitate serum antibody specific 
for the antigen bound to the particular immunoadsorbent 
column. If all the antibody in a serum specific for a 
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particular antigen could be quantitated, the titer of a 
serum in a passive hemagglutination test or indirect fluor-
escent antibody test could be correlated with a concentra-
tion of antibody. Initial work involved a BSA Sepharose 
4B preparation. The data recorded in Table 6 for BSA-
Sepharose 4B experiments were obtained before mechanical 
difficulties with the spectrophotometer readings (mentioned 
in Results) developed. Although the column antigen sites 
appeared to be saturated in all four runs (as determined 
in ring tests), two groups of values (11/21/75-2.64 mg/ml, 
12/6/75-2.81 mg/ml, and 12/26/75-1.53 mg/ml, 12/10/75-1.80 
mg/ml) which differ significantly from each other were 
obtained for specific anti-BSA antibody concentration. 
Values obtained for eluted antibody concentrations obtained 
from other samples reveal that the same volume of anti-
serum did not always yield the same amount of antibody in 
the eluted fraction (Table 6: BGG, 6/14/76 or BGG, 4/22/76). 
Also, in some cases as the volume of the antiserum passed 
over the column increased, the mg of antibody recovered in 
the eluted fraction increased (Table 6: RGG, 1/29/76; RSA, 
4/16/76; BGG, 4/29/76; HGG, 5/10/76- in reference to anti-
HLC serum), decreased (Table 6: RGG, 1/30/76; HSA, 5/19/76), 
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or remained the same (Table 6: BGG, 6/14/76-successive 
samples are listed in the order passed over the immunoad-
sorbent). Thus, there appears to be a dynamic relationship 
between the volume of antiserum passed over the column and 
the amount of antibody bound. Therefore, the efficiency 
of adsorbtion of specific antibody from sera using the 
Sepharose immunoadsorbents may be unpredictable. 
From passive hemagglutination assay data on titers 
of effluent fractions recorded in Tables 9-16, it is appa-
rent that in no single experiment was antibody specific 
for the antigen on the immunoadsorbent completely adsorbed 
out. With the exception of the 2.0 ml effluent fraction 
of the NRS reconstituted serum affinity sample from 5/19/76 
recorded in Table 9 and the 3.0 ml effluent fraction from 
6/21/76 rec·orded in Table 10, as the volume of antiserum 
passed over the column increased, the titer of the effluent 
fraction remained the same or increased. With the excep-
tion of the 1.0 ml and 1.5 ml samples from 4/29/76 recorded 
in Table 13, all titers of serum reconstituted eluted frac-
tions either increased or remained the same as the volume 
of the antiserum passed over the column increased. There-
fore, it cannot be determined from the data whether all 
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antigen sites were saturated on an immunoadsorbent during 
any particular experiment. 
The significance of this finding may lie in a pos-
sible role of specific antibody binding physically blocking 
binding of antibody to other antigenic determinants. An 
optimum "order" of binding of antibody to the determinants 
of a Sepharose bound antigen may exist, such that binding 
of an antibody molecule to a particular determinant may 
physically block binding of antibody to other determinants 
on the same antigen molecule, due to the proximity of the 
other determinants to the Sepharose gel. Therefore, satur-
ation of all possible antibody binding sites may be impos-
sible, and the degree of saturation may vary from experi-
ment to experiment, thus explaining the variable amounts 
of antibody isolated when samples of the same serum were 
passed over the same immunoadsorbent. 
To determine if the absorbance at 280 nm of the 
eluted fractions was due solely to rabbit gamma globulin 
and not other serum proteins, immunoelectrophoresis of 
material from the pooled eluted fractions of the four anti-
BSA experiments reported in Table 6 was run. As evidenced 
by the precipitation of anti-RGG and anti-WRS with the 
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eluted fraction of rabbit anti-BSA and RGG antigen (see 
Fig. 4), the eluted fraction contains gamma globulin free 
of other serum proteins. Therefore, the absorbance at 
280 nm of eluted fractions may be used to determine· the 
concentration of.eluted antibody. 
Initial proof of the specificity of eluted anti-
body was the precipitation of eluted antibody in ring tests 
.. 
with a solution of the homologous antigen. Figs. 3A, 3B, 
and Table 7 give the results of a dual test.for both the 
specific and cross reactivity of eluted antibody. An in-
dication of the activity of eluted antibody is the simi-
larity in the size of the area under the curves of respec-
tive effluent and eluted fractions from successive runs of 
the antibody solution on the same irnmunoadsorbent. Ring 
tests of the effluent fractions displayed in Fig. 3A vs. a 
BSA antigen solution gave no precipitation. It cannot be 
determined whether this result is due to non-specific or 
inactive antibody. The ability of the HSA-Sepharose 4B 
preparation to show cross reactivity of BSA antibody with 
HSA antigen is indicated by the eluted fractions displayed 
in Fig. 3B from a run of anti-BSA antibody over the HSA 
column; antibody from the eluted fractions precipitated 
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with both HSA and BSA in ring tests. 
The ability of Sepharose immunoadsorbents to iso-
late cross reactive antibody should serve as a warning for 
investigators using the irnmunoadsorbents to isolate speci-
fic antibody. If the isolated antibody is to be used in 
experiments requiring specificity for homologous antigen 
alone, the eluted antibody fraction should first be ad-
sorbed with the appropriate cross reacting antigens. 
The discrepancy between total area under curves 
in Fig. 3A (2143 square units) and Fig. 3B (2770 square 
units) is best explained by the method used to calculate 
the curves. As shown in Figs. 3A and 3B, the curves re-
presenting the absorption of the eluted fractions failed 
to return to baseline. Therefore, arbitrary base lines had 
to be drawn to facilitate calculation of the areas under 
the respective eluted fraction curves. Although the inves-
tigator believes that lines were drawn consistently for the 
two eluted fractions in each figure, a discrepancy may have 
arisen in the comparison of the total areas under curves 
between figures. 
Results of other experiments supporting the abil-
ity of Sepharose immunoadsorbents to isolate cross reactive 
antibody are reported in Tables 14 and 15. Recoveries of 
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hemagglutinating activity of NRS reconstituted serum affi-
nity samples from passage of two consecutive 1.0 ml samples 
of a goat anti-RGG serum over a BGG-Sepharose immunoadsor-
bent were 3/3 and 2/3 on RGG coated RBC (Table 14) and 
2.5/3.5 and 3.25/3.5 on BGG coated RBC (Table 15). A com-
parison of the cross reactivity of serum affinity samples 
from passage of a 1. 0 ml sample of anti-BGG serum over the 
RGG-Sepharose immunoadsorbent was limited by the low titers 
of the BGG standard serum on RGG coated RBC as reported in 
Table 14 (non-reconstituted fractions: 1,280; NRS recon-
stituted fractions: 160). 
The increased fluorescence observed in indirect 
fluorescent antibody test on carbohydrase treated kidney 
sections vs. untreated human kidney sections with anti-GBM 
and anti-SCM .sera has been documented (3, 4). In the 
future, the effect on antigenicity of GBM and SCM prepar-
ations treated to remove carbohydrate moieties will hope-
fully be observed by binding such antigens to Sepharose 
and observing differences in antibody binding as compared 
to Sepharose preparations of homologous antigens not 
treated with the specific enzyme involved. 
Data recorded in Table 8 indicate that Sepharose 
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immunoadsorbents will be useful tools in such studies. The 
results indicate that although proteose bound to Sepharose 
less efficiently (Table 5: #1, 0.01 umol/ml; #2, o •. 04 umol/ 
ml) than sialidase treated proteose (Table 5: #1, 0.03 umol/ 
ml; #2 0.05 umol/ml), the combining ratios indicate that 
sialidase treated proteose bound less antibody (Table 8: 
#1, .024, .011; #2 .011, .013) in each case as compared 
to the untreated proteose preparation (Table 8: #1, .081, 
.076; #2, .017, .021, .017), suggesting that removal of 
sialic acids destroyed major antigenic determinants which 
the· antiserum was specific for. 
A seemingly paradoxical result occurred when deter-
mining titers with proteose and sialidase treated proteose 
RBC; RBC coated with sialidase treated proteose consistently 
gave higher titers with eluted fractions from runs on both 
proteose and sialidase treated proteose Sepharose columns 
(data not shown). Therefore, a better explanation for the 
basis of the combining ratios may be that removal of sialic 
acids allowed the proteose to bind to Sepharose in a manner 
that sequestered major antigenic determinants from the anti-
serum. Thus, it could not be assumed that a precipitous 
drop in the adsorption of specific antibody from a serum 
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using an enzyme modified antigen immunoadsorbent, as com-
pared to a native antigen immunoadsorbent, was due to re-
moval of a particular moiety of the antigen: The effect, 
if any on binding of the antigen to Sepharose after enzyme 
digestion of the antigen should always be determined. 
Although the hemagglutinating activity of the ef-
fluent fractions were drastically lower than titers of 
original sera, with few exceptions (Table 13: 1/30/76 
and 1/31/76), the log2 of the serum affinity sample titer 
did not equal the log2 of the respective standard serum 
titer. 
An assumption was made that perhaps the antibody 
in the eluted fractions was being non-specifically adsorbed 
by the polyvinyl Microtiter plates, due to too low a pro-
tein concentration in the eluted fractions. This phenomenom 
has been reported and the high affinity of IgG for fresh 
plastic is in fact taken advantage of in radioimmunoassay 
procedures (17). 
Therefore, to raise the protein concentration of 
the eluted fraction, an aliquot of the fraction was diluted 
1: 2 in NRS. Initially, the tite·rs of several HSA samples 
were redetermined. By observing Table 9, with careful 
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consideration for titers of standard serums in each case, 
it can be seen that some NRS reconstituted eluted fractions 
did in fact show a respectable gain in titer with the cor-
responding loss of hemagglutination activity by the respec-
tive effluent fractions. Titers were redetermined for the 
other completed samples using the 1:2 NRS reconstitution 
technique; all titers of samples obtained afterward were 
determined using only NRS reconstituted eluted fractions. 
However, regardless of whether the eluted fractions 
were reconstituted with normal serum, the fact remains that 
in the majority of cases the hemagglutinating activity of 
the original antiserum {standard serum) is not totally 
recovered in the serum affinity sample. Whether this is 
a result of irreversible protein denaturation caused by 
the elution through reconstitution steps of handling the 
fractions {elution by acidic buffer, neutralization of the 
fraction with base, dialysis, lyophilization, and reconsti-
tution with BBS) and/or by storage of the eluted antibody 
in buffer is not known. 
Numerous reports in the literature involving use 
of Sepharose immunoadsorbents fail to mention data on the 
activity of the isolated antibody. Frequently, it cannot 
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be determined if a specific manipulation on the isolated 
antibody fraction (e.g. concentration) was required before 
the results involving the isolated antibody were obtained. 
Therefore, mention of the activity in_an immunologic test 
of antibody isolated using irnmunoadsorbents should always 
be given. 
A partial explanation for the cause of the appa-
rent denaturation of eluted antibody may be found in a 
report by Jaquet et al. (20). Using a DNP-BSA-polyacryl-
amide gel imrnunoadsorbent, anti-dinitrophenyl antibodies 
were isolated from MOPC-315 (an IgA myeloma) ascites fluid. 
A 0.1 M glycine-HCL buffer, pH 2.3, was used to elute the 
specific antibody from the irnmunoadsorbent. Titers of 
unadsorbed ascites fluid (3,340,800 were compared to 
titers of a 10.0 ml adsorbed (208,800) fraction and re-
spective eluted fractions (50,200 and 6,400-the investiga-
tors split the eluted fraction on the basis of ascending 
and descending fractions of the elution Gurves) in passive 
hemagglutination assays on DNP-coated RBC. In the termin-
ology of this thesis, the titer of the standard serum 
(unadsorbed ascites fluid) had a log2 of approximately 11.5, 
while the titer of the serum affinity sample (adsorbed 
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ascites fluid plus eluted fractions) had a log2 of approx-
imately 14.5. Results for a 5.0 ml sample were 11.5 for 
the "standard serum" and 12.25 for the "serum affinity 
sample". 
Prior to the assays, the concentration of each of 
the two eluted fractions apparently had been adjusted to 
6.0 mg protein/ml. The pH of the fractions from the ascen-
ding portion of the elution curve were "basic". The pH 
of the fractions from the descending portion of the elution 
curve were acidic, and were adjusted to pH 7.5 by the ad-
dition of 0.5 M Tris buffer, pH 8.0. Since the fractions 
were concentrated by negative pressure and dialyzed against 
PBS before use, the loss of activity in the fractions ob-
tained from the descending portion of the elution curve 
were probably a direct result of the acidic conditions in 
which they were initially collected. 
During.the coupling stage in the preparation of 
the RGG and BGG columns, essentially all of the ligand 
added bound to the Sepharose (Table 5). With the excep-
tion of HGG, no other antigen used in the course of ·the 
experiments displayed such a high binding efficiency. 
However 11 the high titers of the effluent fractions recorded 
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in Table 13 suggest that the RGG-Sepharose preparation was 
a very poor inununoadsorbent. Hemagglutination data recorded 
in Table 12 for BGG showed some of the lowest recovery of 
hemagglutinating activity in eluted fractions as compared 
to the other antigen-Sepharose systems. 
The assumption was made that the binding of RGG 
and BGG to Sepharose was fundamentally different in some 
unknown fashion as compared to the other antigens used, 
and that as an antiserum was passed over the RGG-Sepharose 
' 
or BGG-Sepharose columns a great deal of non-specific ad~ 
sorption of serum proteins was occurring with possibly a 
concomitant loss of the original antigen from the column. 
As a result, with respect to antigen specificity the exact 
nature of the antibody obtained in the elution step in 
experiments with RGG-Sepharose and BGG-Sepharose columns 
appeared questionable. 
Hofstee (10) has reported a high degree of essen-
tially irreversible non-specific binding of proteins to 
ligand Sepharose preparations. In an attempt to determine 
if non-specific binding of serum proteins was occurring and, 
therefore, affecting the binding and elution of specific 
antibody, amino acid analyses were determined on RGG-
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Sepharose, BGG-Sepharose, and trypsin solubilized GBM 
)10,000 dalt.-Sepharose before and after use in affinity 
chromatography experiments. In Table 4, results are re-
ported in umol/100 umol since a significant increase in 
the percent composition of a group of amino acids over 
other amino acid constituents would indicate binding of 
serum proteins other than imrnunoglobulin to the column. 
With the exception of arginine, histidine, glutamic 
acid, valine, methionine, and alanine, there is probably 
no significant difference between the amino acid content 
of the unused and used GBM preparations. A good indication 
of the stability of the gel is given by the mg protein/ml 
gel figures for the unused (0.26) and used (0.30) gels. 
Significant differences in the amino acid content of the 
unused and used gels of RGG are apparent with respect to 
lysine, aspartic acid, alanine, valine, leucine, tyrosine, 
phenylalanine, threonine, proline and methionine. Dif-
ferences in amino acid content of the BGG preparations were 
present with respect to histidine, arginine, serine, aspar-
tic acid, proline, valine, half-cystine, isoleucine, leucine, 
tyrosine, methionine, and glycine. The vast difference in 
mg protein/ml gel between the unused (RGG: 0.70, BGG: 1.44) 
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and used (RGG: 1.61, BGG: 3.02) preparations would seem 
to indicate a great deal of protein binding after passage 
of sera over the columns that was stable to elution with 
the glycine buffer. 
When trying to formulate an explanation for the 
• binding of proteins which were stable to elution with gly-
cine-HCL buffer, one is faced.with the difficult task of 
attributing the binding to properties of either the antigen 
itself or as a result of interaction of the bound antigen 
with Sepharose. The amino acid composition of the GBM-
Sepharose, the only non-irnrnunoglobulin Sepharose prepara-
tion analyzed, indicates that the same theories would not 
be applicable to the GBM-Sepharose preparation. Heinzel 
et al. (16) reported that urethan groups, which arise from 
the imidocarbonate groups produced by activation of Seph-
arose with CNBr, were capable of binding other serum proteins 
which were then eluted off along with specific antibody. 
Possibly, elution of non-specific proteins from urethan 
groups may be prevented on the irnrnunoglobulin Sepharose 
irnrnunoadsorbents. This fact, coupled with possible dena-
turation of the irnrnunoglobulin ligand attached to Sepharose 
due to repeated passage of an acidic buffer during elution, 
may explain the decrease in efficiency of the RGG and BGG 
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columns with use, as observed by this investigator, after 
comparing graphs of elution peaks from early and late runs 
of the same volumes of sera (data not shown). Another pos-
sible explanation for the decrease in efficiency may be 
that column antigen was eluted off along with the eluted 
antibody. The increased protein concentration of the used, 
compared with unused, preparations argues against this theory. 
Secondly, the stability of Sepharose bound antigen is sup-
ported by results of immunoelectrophoresis of the eluted 
fraction from chromatography of a goat anti-RGG serum over 
a RGG-Sepharose column, shown in Fig. 4, which revealed 
that anti-RGG formed a precipitin arc with RGG (the .iden-
tical preparation used as ligand for the RGG Sepharose 
column) but not with the eluted fraction of the goat anti-
serum. Therefore, loss of column bound antigen in the 
eluted fraction was not detectable. 
Another consideration arising from Table 4 is the 
disparity between the mg ligand bound/ml gel as calculated 
by the dry weight of ligand recovered (reported in Table 5) 
and the mg protein/ml gel as determined by amino acid anal-
ysis. In all probability this observation was due to the 
hydrolysis of the protein while attached to Sepharose, since 
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hydrolysis of protein in the presence of carbohydrate may 
result in very large losses of amino acids (15). 
The amino acid analysis recorded in Table 3 for 
trypsin solubilized SCM )10,000 dalt. was in fairly close 
agreement with an analysis reported by Lange (25) for a 
PGT-SCM fraction. The trypsin solubilized GBM )10,000 dalt. 
bears little resemblance to a PGT-GBM fraction isolated 
previously (25). The amino acid analyses of the fractions 
resultant from trypsin digestion of GBM did indicate that 
the four different fractions were of significantly differ-
ent amino acid composition, but have some basic similari-
ties between amino acids in highest (glycine, hydroxypro-
line) concentration. 
Data recorded in Table 16 for hemagglutination of 
GBM coated RBC by an anti-PGT HuGlom II serum [a serum 
chosen because of the strong necrotic reaction it produced 
on guinea pigs recorded in Table 17, and also the strong 
fluorescence obtained from it in indirect fluorescent anti-
body tests (3)] and the effluent and eluted fractions of 
the serum recovered after chromatography on the GBM-Sepha-
rose column, indicate that trypsin solubilized GBM )3,500 
<8,000 dalt. shares antigen(s) in common with trypsin solu-
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bilized GBM>10,ooo dalt. The GBM (3,500)8,000 dalt. may 
in fact be a subunit of the larger structure, indicated by 
the fact that the smaller m. w. fraction contains signifi-
cantly higher percentages of lysine and arginine than the 
)10,000 dalt. fraction. Therefore, cells coated with tryp-
sin solubilized GBM )3,500(8,000 may be coated with a pre-
paration which is greatly enriched in the significant antigen 
as compared to the cells coated with the trypsin solubilized 
GBM )10,000 dalt. However, it may be questionable to ex-
plain the observed difference in titers on the basis of a 
concentration effect of antigen alone on the cells. Mini-
mal concentrations of antigens on the RBC are necessary to 
give positive hemagglutination reactions, indicated by the 
fact that supernatants from a first coupling of cells may 
be used to couple a second batch of cells, and th~t too 
much antigen causes autoagglutination of the RBC (8, 37). 
Also, Sheoiri (35) reported that over a fairly wide range 
of antigen concentration (4,700 HGG molecules/REC to 58,500 
HGG/RBC), a constant antibody concentration (SO molecules/ 
RBC) displayed approximately the same titer • 
. An important point to be derived from Table 16 is 
that a method has been devised to concentrate effectively 
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an immunological reagent and thereby increase its sensiti-
vity for the detection of antigen. Usefulness of the method 
was borne out with the knowledge that the concentrated 
eluted fraction of anti-PGT HuGlom II gave more intense 
fluorescent staining than the original serum. Another 
point derived from the fluorescent antibody tests is that 
the results prove that the antibody isolated by affinity 
chromatography and reactive for a solubilized GBM prepara-
tion was reactive also for the antigen in situ. 
--
Rapaport et al. (33) reported the production of 
hemorrhagic necrosis in guinea pigs by intradermal injec-
tion of anti-group A, type 12 SCM sera followed by challenge 
with 100 ug epinephrine intradermally into the same site 
15 min later. The hemorrhagic necrosis elicited was simi-
lar to that described by Thomas (40) in rabbits using an 
intradermal injection of endotoxin followed by challenge 
with epinephrine. Although necessary for the necrotic 
reaction, the method by which epinephrine exerts its poten-
tiating effect is unknown. Thomas theorized that endotoxin 
exerted an effect on blood vessels which altered their re-
activity to epinephrine to an extent that the hormone became 
a potent necrotizing agent (40). 
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The reaction produced using anti-SCM sera is believed 
to be due to a cross reaction between the injected anti-SCM 
antibodies and host tissue. Utilizing antisera prepared 
against group A, type 12 SCM and solubilized fractions of 
type i2 SCM, Lange obtained data consistent with a group 
distribution of the cross reacting antigens in the outbred 
strain of Hartley guinea pigs used (27). 
Recorded in Table 17 is the first report of the 
cross reaction between GBM antigens and guinea pig tissue 
antigens, as indicated by the strong hemorrhagic necrosis 
produced by anti-HuGlom #8, anti-SLS-CNBr-GBM #i2, anti-
trypsin-res. GBM #14, and anti-PGT-HuGlom II. As indicated 
in Results and recorded in Table 17, a large number of the 
antisera prepared against the same SCM preparation produced 
varying degrees of necrosis. This result is probably due 
to the antibody response of the individual rabbit inununized 
with the particular SCM preparation, if the assumption by 
Lange (27) of the group distribution of the cross reactive 
antigens is correct. 
In the future, GBM and SCM Sepharose inununoadsor-
bents may provide a method for determining the basis of 
the variability in severity of necrosis caused by antisera 
104 
prepared against various GBM and SCM antigens. Antigens 
identical to. those used to irmnunize rabbits from which the 
sera were obtained would be coupled to Sepharose. Specific 
antisera would be run over homologous immunoadsorbents, 
and the specific antibody isolated. An equal amount of 
each specific antibody population would be dissolved se-
parately in an equal volume of NRS (previously shown to 
cause no hemorrhagic necrosis), and the hemorrhagic necrosis 
produced by each preparation on the same and different 
guinea pigs compared. Using this method it may be deter-
mined (i) whether the severity of hemorrhagic necrosis pro-
duced by an antiserum was due to the response of an indi-
vidual rabbit, or antigenic characteristics of the particular 
guinea pig tissue; and (ii) whether a particular antigen 
preparation contained the antigens irmnunologically related 
to guinea pig tissue. As an explanation, if the titer of 
a particular antiserum vs. the antigen was lower than the 
titer of another antiserum prepared against the same antigen, 
a simple concentration step (similar to the concentration 
of the anti-PGT-HuGlom II eluted fraction-see Table 16) on 
the eluted fraction of the former would bring its activity 
up to the activity of the latter. However, one rabbit may 
105 
have responded selectively to certain determinants in the 
antigenic preparation. Another rabbit challenged with the 
same antigen could respond selectively to another group 
of determinants. In this case, the antiserum containing 
antibody in high titer against the GBM or SCM antigens 
immunologically related to guinea pig tissue would cause 
the strongest reaction, regardless of whether the concen-
trations in the two antisera of antibody specific for the 
original antigen were equal. If an antiserum against a 
particular antigen did not produce necrosis, a specific 
antibody could be obtained using the appropriate imrnunoad-
sorbent. After concentrating the eluted fraction, if 
hemorrhagic necrosis was still not produced, then it could 
be stated with greater certainty that the antibody specific 
for the GBM or SCM preparation was not cross reactive with 
guinea pig tissue antigens. 
A problem with the above hypothesis is the lack of 
knowledge concerning the loss of activity of specific anti-
body isolated utilizing Sepharose imrnunoadsorbents. Since 
some loss of antibody activity is unavoidable, a system 
must be devised in which the loss of antibody activity can 
be predicted with consistency. 
CHAPTER V 
SUMMARY 
Sepharose 4B immunoadsorbents were constructed 
using as antigens RGG, BGG, HGG, BSA, HSA, protease, sial-
idase treated protease, trypsin solubilized GBM )10,000 
dalt., and trypsin solubilized SCM)l0,000 dalt. The 
inununoadsorbents were used for the investigation of their 
ability to isolate, free of other serum proteins, specific 
and cross reactive antibody for the antigen coupled to the 
inununoadsorbent. An attempt was made to devise a method, 
using the Sepharose inununoadsorbents, for determining the 
concentrations in sera of specific antibody. The effect 
of enzymatic digestion of antigen on the binding of the 
antigen to Sepharose and subsequent adsorption from sera 
of specific antibody on the inununoadsorbent were inves-
tigated using proteose and sialidase treated proteose. 
Stability of immunoadsorbents was investigated using amino 
acid analysis of inununoadsorbents before and after passage 
of sera. 
Recovery of antibody activity was determined using 
passive hemagglutination assays. Titers were determined 
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on effluent and eluted fractions obtained from passage of 
a serum sample over an immunoadsorbent. Titers were re-
ported as the reciprocal of the dilution and the log2 of 
the dilution. The sum of log2 of titers of respective 
effluent and eluted fractions (each matched effluent and 
eluted fraction being termed a "serum affinity sample") 
were compared to the log2 of the titer of the original 
serum (termed "standard serum") to obtain an idea of the 
recovery of antibody activity in the serum affinity samples. 
Eluted antibody fractions were reconstituted (1/1) in 
normal serum in an attempt to optimize recovery of hemag-
glutinating activity. 
The use of Sepharose immunoadsorbents for quanti-
tating the entire antibody content of a serum specific for 
a particular antigen had a limited applicability. Using 
immunoelectrophoresis, the antibody eluted from the columns 
was established to be specific and free of other serum 
proteins, but may have shown a high loss of activity as 
determined in hemagglutination assays. For most immuno-
logic testing it was necessary to reconstitute the eluted 
fraction in a serum fraction in order to regain optimal 
activity. The Sepharose immunoadsorbents have been shown 
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to be capable of isolating cross reactive antibody. Enzy-
matic digestion of antigen may have significantly altered 
the binding of the antigen to Sepharose ~nd thereby blocked 
possible antigenic determinants, thus decreasing the ef-
ficiency of the immunoadsorbent to adsorb specific anti-
body from ser~. The stability of Sepharose immunoadsor-
bents and/or apparently irreversible binding of serum 
proteins on Sepharose immunoadsorbents may depend on the 
particular antigen used for the immunoadsorbent. A new 
potent GBM antigen may have been isolated, but further 
proof will be necessary since decisions based on hemag-
glutination titers alone may be fallacious. A quick and 
easy method has been devised to concentrate specific 
antibody and thereby improve the detectability of its 
interaction with antigen. Finally, the production of 
hemorrhagic necrosis in guinea pigs using anti-GBM anti-
sera has been reported. 
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